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CHAPTER 1 
 
General introduction and outline of this thesis 
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Preterm birth 
 
Preterm birth is defined as childbirth occurring before 37 completed weeks of gestation 
(1). It is estimated that preterm births occur in 5-13% of all pregnancies in the Western 
world with variations from country to country (2-4). The current rate of preterm birth in 
the Netherlands is for example 7.7% with 1% being born before the 32nd week of gestation 
(5, 6). Preterm birth is a significant public health burden, as it is associated with high risk 
of infant mortality, various morbidities in both the neonatal period and later in life, and 
has a significant societal economic impact (7-11). For example, preterm birth still account 
for up to 75% of all perinatal mortality and morbidity in the Western world, despite the 
advances in medical care (6). 
 
Causes of preterm birth can be divided into two main categories: indicated preterm birth 
and spontaneous preterm birth. The first category consists mostly of infants delivered by 
caesarean section based on medical indications of maternal or fetal health (12). These 
include severe intrauterine growth retardation (IUGR), maternal pre-eclampsia and HELLP 
syndrome (haemolysis, elevated liver enzymes, low platelets) (13). The second category 
consists of preterm labor with intact membranes or with premature preterm rupture of 
membranes (PPROM) (12,14). This category is often associated with intrauterine infection, 
as bacterial infection of the intrauterine environment is present in many cases of preterm 
birth. The incidence increases with lower gestational age and reaches an incidence of 70% 
at 24 weeks of gestation (15-17). 
 
Chorioamnionitis 
 
Intrauterine infection often does not affect the mother and therefore remain clinically 
silent. Consistently, the duration of fetal exposure to an inflammatory stimulus is seldom 
known. Intrauterine infection may be diagnosed by histological examination of the 
placenta after birth (18,19). If both the chorionic and amniotic membranes are inflamed, 
this is referred to as chorioamnionitis. Chorioamnionitis exposes the fetus to 
proinflammatory mediators primarily by fetal breathing and swallowing of amniotic fluid, 
affecting the fetus in a multi-organ way (Figure 1). The exposure to chorioamnionitis is 
until now primarily attributed with alterations in lung development. Besides having effects 
on the lung, it is associated with increased risk for necrotizing enterocolitis (NEC), 
retinopathy, cerebral palsy (CP) and white matter damage (WMD) (20-22).  
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Figure 1: Organs known to be affected in preterm infants after prenatal exposure to inflammation (23). 
 
The major factor limiting viability in extremely preterm infants is the development of the 
lung, because this is one of the last organs to mature in the womb (24). Extremely preterm 
birth is associated with an increase in the incidence of chronic lung disease of prematurity 
(bronchopulmonary dysplasia; BPD) with important long-term consequences on airway 
and lung function (25). In addition, gender differences for short and long-term outcomes 
after preterm birth are well recognized in the perinatal field. The lung development of 
female fetuses is for example faster than in male fetuses and is associated with an 
increased surfactant production (26-29). Male gender has almost invariably been 
associated with poor outcomes, including increased risk of developing respiratory distress 
syndrome (30,31), neurodevelopmental delay (32), abnormal cardiovascular development 
(33-35) and neonatal mortality as such (30,36). A gender difference in susceptibility for 
chorioamnionitis-associated adverse outcome may explain part of the discrepancy 
between male and female outcomes after preterm birth. However, there is still a lot of 
speculation about the underlying mechanisms for the female advantage in survival after 
preterm birth, since only a few studies have focused on gender differences as a major 
outcome and topic. 
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Lung development 
 
Immaturity of the lung is the major factor limiting viability in extremely preterm infants. 
The threshold of viability is determined by gestational age since the preterm lung cannot 
facilitate proper gas exchange necessary for survival in the extrauterine environment. Gas 
exchange is regulated in utero by the placenta, from where oxygen is transported to the 
fetus through the umbilical cord. The lungs are not necessary for life inside the uterus and 
the fetal circulation partially bypasses the lung through the ductus arteriosus, which 
connects the pulmonary artery to the aorta. Although fetal breathing movements are 
present from the second trimester onwards, their function is to stimulate lung 
development but they do not affect or regulate gas exchange (37). In postnatal life, the 
lungs fulfill a crucial function in the development of other organs, as they supply the 
oxygen which the newborn needs to grow and develop into a healthy adult. The lung 
needs around 140 m2 in the adult lungs for gas exchange to supply enough oxygen to the 
circulation. To achieve such a large gas exchange area, the lung is made up of branched 
airways in a tree-like structure. 
Human lung morphogenesis starts around the 4th week after conception and can be 
divided into various stages based on histological appearance (Figure 2): embryonic stage 
(4-9 weeks), pseudoglandular phase (7-17 weeks), canalicular phase (16-27 weeks), 
saccular phase (24-36 weeks), and alveolar phase (36 weeks-postnatal). These phases 
overlap somewhat, as the rostral side of the lungs develops slightly faster than the caudal 
side. Through successive stages of branching, the terminal bronchioles are formed in the 
pseudoglandular phase (38). Simultaneously, the pulmonary vasculature is formed 
through progressive branching from the pulmonary artery (39). The terminal bronchioles 
sprout several canaculi during the canalicular phase, which grow to become respiratory 
bronchiole and alveolar ducts. These structures will form the functional respiratory part of 
the lungs. During the last phase of lung development in utero, which is called the alveolar 
phase, functional alveoli are formed through a process of secondary septation which 
subsequently increases the surface area needed for optimal gas exchange (40). 
This process is orchestrated by interactions between myofibroblasts, extracellular matrix 
proteins, the vascular endothelial cells and the airway epithelial cells. Pulmonary 
myofibroblasts produce focal deposits of elastin, which functions as a structural navigator 
for the formation of the growing alveolus (40). Mature alveoli are characterized by a 
dense structural organization and an extremely thin blood-air barrier, facilitating highly 
efficient gas-exchange (39). In addition, a low alveolar surface tension is essential to 
prevent alveolar collapse during expiration, which is accomplished by surfactant secretion 
through the alveolar type II cells. 
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Figure 2: Stages of prenatal lung development (38). 
 
Innate immune system 
 
Fetal responses to infection must rely on innate immune signaling. Innate immune 
responses against microorganisms may have a significant impact on the success of 
pregnancy, as intrauterine infections have been shown to be strongly associated with 
certain complications of pregnancy. The innate immune system is the immunological first 
line of defense that provides an immediate response against invading pathogens (41,42). 
Activation of innate immunity is a critical step to the development of antigen-specific 
acquired immunity. Growing evidence shows that the innate immune system is activated 
at the maternal-fetal interface. For instance, innate immune cells such as natural killer 
(NK) cells, macrophages, and dendritic cells are known to infiltrate the decidua and 
accumulate around the invading trophoblasts (42-46). In addition, Toll-like receptor (TLR) 
2 and TLR4 receptor levels in the chorioamnion are low and increase with preterm or term 
labor. Intra-amniotic lipopolysaccharide (LPS), which induces chorioamnionitis and lung 
injury, signals via TLR4 to initiate the innate immune response. That is the essential initial 
step for mobilizing inflammatory defenses and subsequently acquired immunity. The fetus 
is capable of sophisticated immune responses despite an immature immune system and 
the immune suppressive state of pregnancy. From animal studies it is known that the fetus 
responded to intra-amniotic LPS with a maximal inflammation at about 2 days and a 
partial resolution of inflammation by 7 days (47). Furthermore, the response to 
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chorioamnionitis induced a maturation of leukocyte cell lineages to alveolar macrophages 
that have increased inflammatory response potentials (48), but also cross-tolerance to 
different TLR-agonists (49). Thus, the naive fetal immune system is capable of complex 
modulations. However, the knowledge of the characteristics of these immune responses is 
limited and need more investigation, since inflammatory processes can affect organ 
function such as in asthma. 
 
Bronchial hyperreactivity and childhood wheezing after preterm birth 
 
In the treatment of preterm newborns, important advances have been made over the last 
decades. These include antenatal steroid administration and exogenous surfactant 
treatment, both of which have greatly improved survival and outcome after preterm birth 
(50,51). However, there are still major adverse outcomes associated with 
chorioamnionitis-induced preterm birth. Children who had been born preterm and 
developed BPD are frequently admitted to hospitals with respiratory infections (52,53). As 
these children grow older, they usually have poor lung function and more frequently 
develop a wheezing phenotype or asthma, compared to age-matched children born at 
term (52,54). Recently, an additional risk factor for asthma in preterm babies was 
identified. Chorioamnionitis is correlated with a 4.4-fold increased risk for developing 
physician-diagnosed asthma in very preterm infants (55).  
Asthma is the most common chronic disease affecting children, causing constriction of the 
airways and air trapping. The most common triggers of asthma include cold air, exercise, 
allergens and some types of viral infections. Contact with these triggers causes 
overreactivity of the airways and leads to inflammation. This results in constriction of the 
airway muscles and swelling of bronchioles (bronchial hyperrreactivity); breathing 
passages are narrowed and breathing becomes very difficult. The outcome is a wheezing 
phenotype or childhood asthma which limits children's daily activities and affects their 
social activities. The link with preterm birth is of significant public health relevance 
because of the increasing incidence of both entities (56,57). Wheezing is common in 
young infants and toddlers with 27% of all children having at least one wheezing episode 
by the age of 9 years (58). For some of these children these asthmatic symptoms seem to 
remit with time, but many children develop asthmatic symptoms which persist throughout 
their life and are associated with more severe symptoms ending in the loss of lung 
function. About 15% of the wheezing infants develop persistent wheezing and clinical 
asthma later in life (59).  
Specific risk factors during pregnancy can influence the risk of wheezing in early childhood. 
Maternal smoking, low maternal age, early bottle feeding, low birth weight and 
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prematurity are associated with lower respiratory tract illness in the first 2 years of life 
(60-68). Prematurity and low birth weight are considered significant risk factors for 
reduced lung function at school age and the development of childhood asthma (62,69,70). 
The underlying mechanisms by which adverse birth outcomes predispose to wheezing is 
not known. It seems to be in contrast to the “hygiene hypothesis”. This hypothesis 
associates the exposure of young children to rural environments with high endotoxin 
levels and a subsequent decreased incidence of childhood asthma (71-74). The 
relationship between antenatal inflammatory exposures and postnatal abnormalities 
seems to be confounded by the fetal response to inflammation, which is difficult to study 
in patients and animal models. Therefore, hardly anything is known about the persistence 
of fetal immune modulations following a pro-inflammatory stimulus and how the duration 
of exposure to antenatal inflammation may affect the fetal response as gestation 
advances till near-term and the first years after birth. Knowledge of these processes is 
necessary for a better understanding of the development of childhood wheezing after 
preterm birth, and for the development of prevention and treatment options for 
childhood wheezing and asthma.  
 
Sheep as a translational animal model of chorioamnionitis 
 
In the last years translational research with various animal models has been helpful to 
answer some basic questions about the effect of various fetal exposures on different 
organs. However, the various animal models differ in their developmental biology 
compared to humans (75).  
Development of the ovine lung is highly similar to that of humans (Figure 3). Sheep 
undergo the alveolar phase of lung development in utero and these animals are large 
enough to induce an intrauterine inflammation for example by LPS (76). The adolescence 
of sheep usually occurs at approximately 11 months of age and sheep with an age of 7 
weeks are comparable to 4-5 years of age in humans.  
Adult sheep have been used as a model of sensitization and airway reactivity frequently. 
Sheep have, in contrast to mice, a bronchial circulation, bronchial glands and mast cells 
that respond to stimuli similarly to the human lung with both early and late phase 
responses (77-79). In addition, sheep can be sensitized to house dust mite antigen which is 
a common human antigen in asthma. The sensitized sheep have allergenоspeciĮc IgE 
responses and acute eosinophil responses to allergen challenge (79). Recently, airway 
remodelling (increased airway collagen and smooth muscle with hyperplasia of goblet 
cells) following repeated airway exposures of sheep to house dust mite (HDM) was 
reported (80). Sheep respond to HDM sensitization and airway challenges with a complete 
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allergic/asthma response similar to that which occurs in humans. Therefore, preterm 
sheep are considered as an excellent translational model to study the effects of antenatal 
events on the developing fetus till adolescence in relation to the development of asthma. 
 
Outline of this thesis 
 
The main focus of this thesis was to give insight into how the lung development and 
airway function were influenced by antenatal inflammation as gestation advances and 
during the first period after birth. We used an animal model with highly similar lung 
development in utero (Figure 3) and allergy response as in human fetal lungs.  
 
Figure 3: Human versus sheep lung development (76). 
 
In chapter 2 we studied how the lung was affected by inflammation as gestation advances. 
Fetal lambs were exposed to one or two doses of LPS into the amniotic fluid and the 
animals were delivered at three different gestational ages, to confirm that intra-amniotic 
LPS exposure would cause persistent fetal pulmonary responses as the lungs develop in 
utero. 
In chapter 3 we assessed how the lung maturational responses to inflammation in utero 
differ between male and female fetuses.  
To study airway reactivity in sheep, a research model had to be developed to visualize and 
quantify airway contractility. In chapter 4 a model of sheep precision-cut lung slices (PCLS) 
was established for the measurement of airway responses to early allergic response 
mediators and allergens in newborn and adult animals.  
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In chapter 5 we assessed how the fetal innate immune responses to LPS-induced 
chorioamnionitis would alter postnatal systemic immune responsiveness and airway 
reactivity at the age of 7 weeks. 
To conclude, Chapter 6 provides a discussion of the presented research results, clinical 
perspectives and a recommendation for future research towards the understanding how 
the developing lung responds to inflammation and how this effects the development of 
bronchial hyperreactivity and asthma later in life. 
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Abstract 
Background: Intra-amniotic lipopolysaccharide (LPS) exposure may affect neonatal 
outcome by altering fetal lung and immune system development. We hypothesized that 
intra-amniotic LPS exposure would cause persistent fetal pulmonary responses as the 
lungs develop in utero. 
 
Methods: Fetal lambs were exposed to intra-amniotic LPS at 118 or at 118 and 123 days 
(d) of gestational age (GA) with delivery at 125, 133 or 140d (term = 147d). Immune 
responses, PU.1 expression, Toll-like receptor (TLR)1,2,4,6 mRNA levels, mast cell levels, 
and pulmonary elastin deposition were evaluated. 
 
Results: After a single dose of LPS, pulmonary inflammatory responses were observed with 
increases of (i) PU.1, TLR1 at 125d GA and (ii) monocytes, lymphocytes, TLR2 and TLR6 at 
133d GA. Repetitive LPS exposure resulted in (i) increases of neutrophils, monocytes, PU.1 
and TLR1 at 125d GA; (ii) increases of neutrophils, PU.1 and TLR2 at 133d GA; and (iii) 
decreases of mast cells, elastin foci, TLR4, and TLR6 at early gestation. At 140d GA, only 
PU.1 was increased after repetitive LPS exposure. 
 
Conclusion: The preterm fetal lung can respond to a single exposure or repeated 
exposures from intra-amniotic LPS in multiple ways, but the absence of inflammatory and 
structural changes in LPS-exposed fetuses delivered near term suggest that the fetus can 
resolve an inflammatory stimulus in utero with time.  
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Introduction 
 
Chorioamnionitis, an intrauterine inflammatory response of the chorioamniotic 
membranes to microorganisms, is a common antenatal exposure for very preterm infants 
that affects up to 70% of preterm deliveries before 30-weeks gestation (1). In 
chorioamnionitis, the fetus is exposed to inflammation through direct contact with 
amniotic fluid or via the placental-fetal circulation (2,3). Often, chorioamnionitis is 
identified only by histological examination of the placental and fetal membranes after 
birth. Consequently, the duration of fetal exposure to an inflammatory stimulus is seldom 
known.  
Chorioamnionitis affects neonatal outcomes in an organ-dependent way (3), but is 
primarily associated with alterations in lung development (4). Chorioamnionitis is 
associated with a decrease in the incidence of respiratory distress syndrome (5), probably 
due to induced structural and functional maturity of the lung (6). Conversely, 
chorioamnionitis is associated with an increase in bronchopulmonary dysplasia (BPD) 
(4,7,8) due to inflammatory disruption of lung alveolar and vascular development (9,10). 
Chorioamnionitis may also negatively affect neonatal outcomes by modulating the fetal 
immune system (3,11,12). The fetal lung, gut and skin are directly exposed to the 
inflammation associated with chorioamnionitis, although other organs and the immune 
system, which are not in direct contact with the amniotic fluid, can also be affected 
adversely (3). 
Neutrophils, monocytes and lymphocytes are increased in the alveolar lavages of preterm 
lambs after a single dose of lipopolysaccharide (LPS) (13). Additionally, intra-amniotic LPS 
exposure induces [i] maturation of monocytes to alveolar macrophages with increased 
inflammatory response potentials by inducing hematopoietic transcription factor PU.1 
(14) and [ii] cross-tolerance to different Toll-like receptor (TLR) agonists (15). Thus, the 
naive fetal immune system is capable of complex modulations that can alter subsequent 
immune function (13). However, our knowledge of the characteristics of these immune 
responses is limited to short-term exposure to proinflammatory agonists. The persistence 
of fetal immune modulations following a proinflammatory stimulus and how the duration 
of exposure to antenatal inflammation may affect the fetal response as gestation 
advances till near term is poorly understood (13,16). Whether such changes in the 
immune system persist after a proinflammatory stimulus may enhance understanding of 
whether preterm/term infants are more susceptible to infections, sepsis and/or 
pneumonia later in life (17).  
We used an ovine model of chorioamnionitis induced by intra-amniotic LPS to evaluate 
how exposure interval changed the lung as the fetus matured. Our hypothesis was that 
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intra-amniotic LPS exposures would cause persistent fetal pulmonary responses as the 
lungs develop in utero. 
 
Materials and methods 
 
Antenatal treatment 
All animal procedures were approved by the Animal Ethics Committee of the University of 
Western Australia. Pregnant Merino ewes received an intra-amniotic (IA) injection with 
saline (sal, 2 mL; controls) or 10 mg LPS (Escherichia coli 055:B5; Sigma-Aldrich, St. Louis, 
MO) at 118 and 123 days (d) gestational age (GA) (Figure 1). The fetuses were delivered 
operatively at 125d (n=21), 133d (n=19) or 140d (n=20) gestation (term=150d). Each lamb 
was killed at delivery with an intravenous injection of pentobarbital (100 mg/kg, Valabarb, 
Jurox, Rutherford, NSW, Australia).  
Delivery at
140 days GA
Delivery at 
133 days GA
Delivery at 
125 days GA
118 days 123 days
IA injection with saline [sal]
IA injection with lipopolysaccharide [LPS]
sal/sal
LPS/sal
LPS/LPS
sal/sal
LPS/sal
LPS/LPS
sal/sal
LPS/sal
LPS/LPS
 
Figure 1: Animal model of intra-amniotic LPS exposure. All animals were exposed to saline (sal) or LPS at 118 
and 123 d GA, resulting in three treatment groups: sal/sal (control), LPS/sal and LPS/LPS. Animals were delivered 
at three different GA’s: 125, 133 and 140d. GA, gestational age; LPS, lipopolysaccharide. 
 
Processing of the fetal lung 
Lung compliance was assessed by measuring lung gas volumes from pressure-volume 
curves as a measure of lung maturation. The thorax was opened with a midline incision, 
and a tracheal tube was inserted and connected to a manometer (18). The maximal 
volume measured at a pressure of 40 cmH2O was recorded as a measure of lung 
compliance. To collect bronchoalveolar lavage fluid (BALF), the left lung was lavaged three 
times with 0.9% NaCl (sal). The BALF samples were pooled and centrifuged at 500 rpm for 
5 min. Differential cell counts were obtained on cytospin preparations after a Pappenheim 
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staining (May-Grünwald, Giemsa) (19). Tissue from the right lower lobe was snap-frozen 
for mRNA analyses. The bronchus to the right upper lobe was cannulated for airway 
fixation with 10% formalin for 24h at 30 cmH2O pressure, followed by transfer into 
phosphate buffered saline (PBS). 
 
RNA extraction and reverse transcription 
Snap-frozen lung tissue from the right lower lobe was cut in 30-mg pieces. The tissue was 
transferred into lysis buffer (RLT buffer Qiagen, Hilden, Germany) for RNA extraction. After 
vortexing, the suspension was transferred to an RNeasy mini column (Qiagen) and 
processed according to the manufacturer’s protocol. The purity and yield of the RNA were 
photometrically determined using a Nanodrop spectrophotometer (Thermo Scientific, 
Wilmington, DE), and 1 ʅg total RNA was reverse transcribed by addition of 2 ʅL oligo (dT) 
primers (10 ʅmol/L), 1 ʅL RNase inhibitor (10 units/ʅL), 2 ʅL deoxynucleotide Mix (5 mM), 
and Omniscript transcriptase (0.2 U/ʅL; Qiagen) and incubation for 1h at 37°C. The cDNA 
was denatured at 93°C for 5 min. 
 
Real-time PCR 
The design of real-time PCR primers was based on published cDNA sequences (20,21). All 
PCRs were performed using 1 ʅg/ʅL cDNA per reaction in duplicates. Real-time PCR 
reactions were performed with the LightCycler 480 SYBR Green I Master mix (4707516001, 
Roche-Applied, Mannheim, Germany) on a LightCycler 480 Instrument according to the 
manufacturer’s instructions. Real-time PCR results of TLR1, TLR2, TLR4 and TLR6 were 
normalized to the housekeeping gene ovine ribosomal protein S15 (ovRPS15), and mean 
fold changes in mRNA expression were calculated by the ȴȴ Ct method (22). 
 
Immunohistochemistry (PU.1  and Clara cell secretory protein) 
Paraffin-embedded lung sections were deparaffinized in an ethanol series, and 
endogenous peroxidase activity was blocked by incubation with 3% H2O2 in milli-Q water. 
Sections were incubated overnight at 4°C with the diluted primary antibody. Staining for 
hematopoietic transcription factor PU.1 (Santa Cruz Biotechnology, Santa Cruz, CA) was 
performed as described (14,16). After incubation with the appropriate secondary 
antibody, immunostaining was enhanced with the Vectastain ABC peroxidase Elite kit 
(Vector Laboratories, Burlingame, CA) and stained with nickel-diaminobenzidine (Ni-DAB). 
After counterstaining with Mayer’s hematoxylin, the sections were washed and 
dehydrated. Sections were scored for PU.1 staining with a semi-quantitative scoring 
system: 1, little staining; 2, some staining; and 3, heavy staining. The analysis was 
performed in a blinded fashion. 
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A lung-specific Clara cell secretory protein (23) was detected in lung sections that were 
incubated overnight at 4°C with the diluted primary antibody (rabbit anti-uteroglobin, 
Abcam, Cambridge, UK). After incubation with the appropriate secondary antibody, 
immunostaining was enhanced as described above, stained with diaminobenzidine (DAB), 
and counterstained with Mayer’s hematoxylin. 
 
Mast cell staining 
Mast cell staining was performed on paraffin-embedded lung sections (4 ʅm, transverse) 
from the right upper lobe (24). Briefly, the sections were stained with Weigert’s iron 
hematoxylin working solution for 10 min. After rinsing with water, the sections were 
stained with 1% toluidine blue in 35% ethanol for 1 min. Subsequently, the sections were 
quickly dehydrated in ethanol and xylol. Microscopic images were taken at x100 and x200 
magnifications using a Leica microscope and Leica Qwin Pro, version 3.4.0, software (Leica 
Microsystems, Mannheim, Germany). The circumference of all bronchi was measured at 
x100 magnification using ImageJ software, version 1.45 (National Institutes of Health, 
Bethesda, MD). Mast cells were counted at x200 magnification in six representative 
sections per animal. The analysis was performed in a blinded fashion. 
 
Elastin staining 
Sections of lung were incubated for 20 min in Weigert’s resorcin-fuchsin (Chroma GmbH, 
Münster, Germany) at 60-70°C (24,25). After rinsing with water, the sections were 
incubated for 3 min in a tartrazine solution at room temperature. Subsequently, the 
sections were washed and dehydrated in ethanol and xylol. Microscopic images were 
taken at x200 magnification and elastin foci were counted in six representative sections 
per animal. The analysis was performed in a blinded fashion. 
 
Data analysis 
Results are given as mean ± standard error (SE). Comparisons between groups were 
performed by two-way analysis of variance (ANOVA) with Bonferroni post-hoc analysis 
(GraphPad Prism version 5, San Jose, CA). Significance was accepted at P < 0.05.  
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Results 
Characterization of fetuses and lungs 
The body weights and lung weights of LPS-exposed lambs were similar to those of the 
control group at each GA (Table 1), indicating similar growth. The cord blood pH, and pCO2 
were not different between groups. 
As anticipated, the LPS-exposed lambs delivered at 125d GA had higher lung gas volumes 
compared with the control group (Table 1). Increased lung volume after LPS exposure 
persisted with delivery at 133d GA. At 140d GA, the control and the treatment groups had 
comparable pressure-volume deflation curves. The number of LPS injections did not 
influence lung gas volumes at any GA.  
 
 
Table 1: Description of animals.  
 
 
BW, body weight. V40 mL/kg BW, lung volume at 40 cmH2O per kilogram body weight. 
*P < 0.05 versus control group of the same gestational age. 
 
 
 
 
Treatment 
No. of 
animals 
BW (kg) 
Lung weight 
(g/kg BW) 
Cord blood 
pH 
Cord blood 
pCO2 
V40 
mL/kg BW 
Delivered at 125d GA 
Control 7 3.0 ± 0.1 35.0 ± 0.9 7.28 ± 0.03 65 ± 3 12.1 ± 1.7 
2d LPS 7 3.0 ± 0.1 31.9 ± 1.3 7.31 ± 0.02 62 ± 3 30.0 ± 2.3* 
2+7d LPS 7 2.9 ± 0.1 38.5 ± 2.8 7.26 ± 0.03 67 ± 2 33.7 ± 2.5* 
Delivered at 133d GA 
Control 7 4.0 ± 0.3 31.4 ± 1.0 7.20 ± 0.02 74 ± 4 27.8 ± 4.8 
2d LPS 7 4.1 ± 0.1 34.3 ± 1.0 7.20 ± 0.01 74 ± 3 37.9 ± 1.8* 
2+7d LPS 5 3.7 ± 0.1 32.0 ± 1.6 7.26 ± 0.02 68 ± 3 38.6 ± 1.1* 
Delivered at 140d GA 
Control 7 5.0 ± 0.2 29.1 ± 0.9 7.25 ± 0.03 67 ± 4 40.9 ± 3.8 
2d LPS 6 5.3 ± 0.1 35.2 ± 3.8 7.18 ± 0.04 80 ± 5 36.1 ± 3.4 
2+7d LPS 7 5.0 ± 0.2 33.4 ± 1.8 7.24 ± 0.04 77 ± 6 37.7 ± 3.4 
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Figure 2: Pulmonary inflammation. Leukocytes were increased in BALF after LPS exposure at gestational ages of 
125 and 133d, with a significant increase of (A) neutrophils and (B) monocytes at 125 and 133d GA. (C) 
Lymphocytes were increased after a single dose of LPS at 133d GA. In panels (B) and (C), the y-axis was adjusted 
for the low number of monocytes and lymphocytes. *P <0.05 versus control group of the same gestational age. 
BALF, bronchoalveolar lavage fluid; GA, gestational age; LPS, lipopolysaccharide; sal, saline. 
0
1
2
3
4 sal/sal
LPS/sal
LPS/LPS
125 d GA 133 d GA 140 d GA
* * *
*
Re
la
tiv
e 
PU
.1
 e
xp
re
ss
io
n
A)
 
C)B) 
 
Figure 3: PU.1 expression in lung tissue. (A) The PU.1-positive cells in lung tissue exposed to LPS differed 
significantly from controls at each gestation. Representative staining (original magnification x200) is shown (B) 
for 125d GA control animals and (C) after two doses of LPS. The high-magnification insets (original magnification 
x400) illustrate the strong positivity of cells for PU.1 after exposure to LPS compared with that of controls. Red 
arrows indicate cells expressing PU.1. *P <0.05 versus control group of the same gestational age. GA, gestational 
age; LPS, lipopolysaccharide; sal, saline. 
Effects of LPS exposure as gestation advances | 
 
 
27 | 
 
Pulmonary inflammation 
The total number of leukocytes increased after exposure to LPS at 125 and 133d GA. 
Neutrophils, in particular, increased significantly in the BALF after two injections of LPS 
(Figure 2A). Monocytes also increased at both 125 and 133d GA (Figure 2B). Lymphocytes 
increased only at 133d GA after a single LPS exposure (Figure 2C). No difference in the 
total number of neutrophils, monocytes and lymphocytes after LPS exposure were 
detected at 140d GA (Figure 2A, 2B and 2C). 
 
PU.1-expressing cells in lung tissue 
Cells expressing PU.1 increased in the lung tissue after two LPS injections at each gestation 
(Figure 3A). Compared with PU.1 expression in control lambs (Figure 3B), the expression of 
PU.1 was high in both alveolar and interstitial cells (Figure 3C). In contrast, a single LPS 
exposure resulted in only a transiently increased PU.1 expression: increased PU.1 level 
was evident at 125d GA, but PU.1 expression was lost at 133 and 140d GA (Figure 3A). 
 
TLR mRNA in lung tissue 
TLR1 mRNA levels increased after one and two doses of LPS at 125d GA (Figure 4A). mRNA 
levels of TLR4 and TLR6 decreased after the two exposures to LPS and subsequent delivery 
at 125d GA (Figure 4C and 4D). However, increased mRNA levels of TLR2 and TLR6 were 
detected at 133d GA (Figure 4B and 4D). No significant differences in TLR mRNA levels 
were detected at 140d GA. 
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Figure 4: mRNA levels of TLR 1,  2,  4 and 6. (A) TLR1 mRNA level was increased after a single dose and after 
double doses of LPS at 125d GA. At 125d GA, mRNA levels of (C) TLR4 and (D) TLR6 were decreased after a 
double dose of LPS. At 133d GA, increased mRNA levels of (B) TLR2 and (D) TLR6 were detected. No differences 
in mRNA levels were detected at 140d GA. *P <0.05 versus control group of the same gestational age. GA, 
gestational age; LPS, lipopolysaccharide; sal, saline; TLR, Toll-like receptor. 
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Mast cells and Clara cells in lung tissue 
Mast cells were present in the bronchial wall but not in other regions of lung tissue (Figure 
5B and 5C). At 125d GA, there was a trend for a decreased number of mast cells with LPS 
(Figure 5A). The decrease in mast cells was significant after two doses of LPS at 133d GA. 
The number of mast cells increased as GA advanced (Figure 5A).  A representative Clara 
cell staining (Figure 5D and 5E) was performed to demonstrate the specificity of the mast 
cell staining. 
125 d GA 133 d GA 140 d GA
0
5
10
15
20 sal/sal
LPS/sal
LPS/LPS
*m
as
t c
el
ls 
/ m
m
A)
 
 
 
Figure 5: Representative staining and number of mast cells counted in the bronchial wall. (A) There were no 
changes in number of mast cells as a result of exposure to LPS with one or two doses compared with the control 
group at 125 and 140d GA. At 133d GA, the number mast cells decreased after repetitive LPS administration. 
Representative staining (original magnification x200) is shown in panel (B) for 133d GA control animals and in 
panel (C), after two doses LPS. The high-magnification insets (original magnification x400) illustrate the loss of 
mast cells after exposure to LPS compared with the number in controls. Panels (D) and (E) represents the 
staining for Clara cells in the bronchial wall. Red arrows indicate mast cells, and green arrows indicate Clara cells. 
*P <0.05 versus control group of the same gestational age. GA, gestational age; LPS, lipopolysaccharide; sal, 
saline. 
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Elastin expression in the lung 
The elastin foci on alveolar septa were counted on sections from the right upper lobe 
(Figure 6A). Elastin foci were reduced in number after two LPS injections at 125d GA. The 
elastin was localized more diffusely in LPS-exposed lungs (Figure 6C), compared with 
control lungs, at 125d GA (Figure 6B). Elastin foci were not different in number or 
localization in lungs of LPS-exposed and control groups at 133 and 140d GA. 
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Figure 6: Expression of elastin foci on alveolar septa in lung tissue. (A) Decreased numbers of elastin foci were 
recorded at 125d GA after a double dose of LPS. At 133 and 140d GA, the lungs showed no differences after LPS 
exposure compared with control animal lungs. The high-magnification insets (original magnification x400) show 
that the focal depositions of elastin on the tips of alveolar septa, which are strongly present in (B) the lungs of 
controls at 125d GA, are diminished and diffusely expressed in (C) lungs after a double dose of LPS at 125d GA. 
Panels (B) and (C) are high-magnification images (original magnification x200). Red arrows indicate location of 
focal expression of elastin, and green arrows indicate diffusely expressed elastin. *P <0.05 versus control group 
of the same gestational age. GA, gestational age; LPS, lipopolysaccharide; sal, saline. 
 
Discussion 
To better characterize the effects of LPS on the fetal lung, we measured a number of 
variables that could contribute to longer-term adverse effects of fetal exposure to LPS. We 
used the single exposure at 118d and the two exposures at 118 and 123d to parallel our 
previous reports that demonstrated fetal immune tolerance to LPS (13,16,26). The 
deliveries at 2, 10, and 17d after the second exposure allowed evaluation of the 
persistence of responses during late fetal development.  
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LPS in the amniotic fluid has a half-life of 1.7d, with inflammation markers remaining 
measurable for at least 15d after administration (27). In this study, intra-amniotic LPS 
exposure resulted in changes in the fetal lung inflammatory responses. This is consistent 
with our previous findings at 125d GA regarding treatment after one or two doses of LPS 
(4,19,28). Our findings show that the increase in neutrophils at 133d was evidence of a 
persistent response to the initial inflammatory stimulus. Furthermore, two doses of LPS 
were required to induce significant differences in BALF neutrophil content at 125d GA. 
This finding suggests that the pulmonary immune response may be dependent on the 
intensity and/or persistence of the LPS exposure. The local immune system of the lung 
seems to remain active until 133d GA, with increased number of monocytes and 
lymphocytes. Interestingly a macrophage response was involved in the pulmonary 
inflammatory response to LPS in the course of gestation, shown by an increased PU.1 
expression. Normally, the fetal lung contains few macrophages, and monocytes mature to 
macrophages with PU.1 expression after term birth (14,29,30). The lungs of fetal sheep 
exposed to intra-amniotic LPS expressed PU.1 within 1-2d, and vacuolated alveolar 
macrophages could be recovered by lavage several days later (14). We reported that PU.1 
expression increased 7d after a single exposure to LPS but that expression was lost 15 and 
22d later. In contrast, the second exposure 5d following the first exposure resulted in high 
PU.1 expression, which persisted until 140d GA. These observations demonstrate that 
monocyte to macrophage maturation in the fetal lung can be transient or persistent 
depending on the characteristics of the inflammatory exposure. In vitro, fetal alveolar 
macrophages responded to TLR agonists similarly to alveolar macrophages from the adult 
lung (15). The persistence of macrophages could promote inflammation in the fetal lung 
or in the lung following delivery after TLR stimulation and may lead to an increased 
susceptibility for neonatal sepsis and pneumonia (17).  
TLR mRNA levels were low in the fetal sheep lung relative to the adult lung, and changes in 
expression are minimal during late gestation (20). Our results demonstrated that changes 
in TLR mRNA levels with LPS exposure differed by TLR, exposure, and interval from 
exposure. TLR4 mRNA levels decreased 2d, but not 7d, following intra-amniotic injection 
of LPS. The delayed increases in TLR2 and TLR6 mRNA levels 15d after the initial exposure 
to the TLR4 agonist LPS might have clinical implications for the chronic infection and often 
polymicrobial organisms associated with chorioamnionitis (17). Interestingly, increased 
TLR2 and TLR6 mRNA levels seem to be related to increased monocytes numbers in BALF 
15d after a single injection, indicating an early development of the monocytes (31). It is 
not clear why there was a resolution of TLR2 and TLR6 to term gestation.  
The homeostasis of the airway is also maintained by mast cells. Mast cells in the lower 
airways contribute to the development of asthma and allergic diseases (32). Mast cells are 
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of interest because of a possible relation between chorioamnionitis, preterm birth, and 
the development of asthma later in life (33,34). Mast cell activation results in 
degranulation, leading to the rapid release of inflammatory mediators, such as histamine, 
proteoglycans, and cytokines, which stimulate the recruitment of other inflammatory cells 
(35). Mast cells are mostly present near epithelial surfaces such as mucosa of the lungs 
and the digestive tract (35). In this study, mast cells were found in the bronchial walls of 
preterm fetal lamb lungs. Although exposure to LPS resulted in a decrease of mast cells in 
the more immature lambs, mast cell numbers had returned to normal for lambs delivered 
near term. Our finding of reduced mast cell populations soon after LPS exposure contrasts 
with our hypothesis that LPS exposure would increase mast cells. However, repeated fetal 
exposures to LPS decreased airway responses to methacholine challenge in 7-week-old 
lambs (12). The relationship between prenatal inflammation and the mast cell response in 
the fetal airways has not been studied. Increased levels of mast cells were associated with 
the development of BPD in one autopsy study (36). Mast cell regulation is complex, 
depending on the timing of the fetal and postnatal stimuli. Our results demonstrated that 
fetal exposure to LPS could change mast cell numbers in the fetal lungs. However, the 
long-term effect of intrauterine exposure to inflammation on mast cell presence and 
function in postnatal life needs to be determined. 
To examine lung structure, elastin foci on alveolar septa were counted on lung sections. 
Although a double LPS exposure resulted in more diffusely localized elastin foci in the 
more immature fetal lambs, a more normal distribution with localization of elastin foci at 
the tips of alveolar septa was reestablished near term, indicating recovery with advancing 
gestation. Whereas a single LPS exposure can induce structural maturation (4,37), a 
second LPS exposure may increase the abnormal elastin distribution and alveolar 
development. In addition, it was demonstrated that prenatal LPS exposure upregulated 
tropoelastin (soluble precursor of elastin) mRNA levels in lung tissue at the time of 
secondary septa development, resulting in a more diffuse elastin expression along the 
alveolar cell wall (38). This might contribute to the abnormal lung structure. The 
mechanism by which the fetal lung repairs the abnormal elastin response is unknown. 
Some of the variables in the “recovery” response, detected in part in this study, may be 
GA at assessment, GA at time of initial exposure (39), and magnitude of the inflammatory 
responses and/or antenatal steroids (40).  
A limitation of our study was that no additional exposure to LPS was given immediately 
before delivery at the different GAs to challenge the fetal immune system. In human 
pregnancies affected by chorioamnionitis, fetuses are exposed to bacteria until delivery, 
which will challenge the immune system continuously. In our model, the fetus had a single 
or a second dose of LPS within a confined GA range, and the proinflammatory stimuli 
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might be less than those occurring in human infants. In this study, we focused on the 
lungs. From literature, it is known that chorioamnionitis is a multiorgan disease that 
affects the central nervous system, skin, and the gut in clinics and experimental models 
(3,41,42). The interaction of the different organs is not very well understood, but the role 
of the immune system of the fetus, as well as the role of endotoxins in human 
chorioamnionitis, warrants further research. 
In summary, the fetal lung responded to intra-amniotic LPS with changes that might have 
long-term effects on lung and immune function. Although the abnormalities in elastin 
distribution did not persist, monocyte to macrophage maturation, selective TLR 
expression, and mast cell numbers could change at later times after the LPS exposure. 
How preterm delivery might interact with these changes remains to be determined. 
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Abstract 
 
Background: Preterm female infants have a survival advantage and enhanced lung 
development, which is an important determinant of preterm survival. Given the 
modulation of lung development by fetal exposure to infection/inflammation, we 
hypothesized that female fetuses have enhanced lung maturational responses to 
chorioamnionitis compared with male fetuses. 
 
Methods: Time-pregnant ewes received intra-amniotic injections with saline (n=60) or 
lipopolysaccharide (LPS) at 2 days (n=30) or 7 days (n=45) before surgical delivery at 123 
to 125 days of gestation (term: ~147 days). We assessed inflammatory responses in 
bronchoalveolar lavage fluid and cord blood, and lung maturation with pressure-volume 
curves, and lung structure. 
 
Results: Lung gas volume showed differences between the sexes after 2 days LPS (male 4.6 
± 1.2 mL/kg, female 7.7 ± 4.4 mL/kg; P = 0.02) and 7 days LPS (male 20.5 ± 9.3 mL/kg, 
female 27.0 ± 7.0 mL/kg; P = 0.01). The control group was not different by sex (male 8.0 ± 
3.6 mL/kg, female 8.9 ± 3.9 mL/kg; P > 0.05). No difference in lung structure and in 
pulmonary and systemic inflammatory response was evident by sex. 
 
Conclusion: Preterm female sheep fetuses had increased lung gas volumes after exposure 
to LPS, without any detectable differences in fetal inflammatory responses. 
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Introduction 
 
In the field of perinatology, sex differences for short- and long-term outcomes after 
preterm birth are well recognized. Male sex has almost invariably been associated with 
worse outcomes, including neonatal mortality (1-3), neurodevelopmental delay (4), and 
abnormal cardiovascular development (5-6). In line with these observations, preterm male 
infants have a higher respiratory morbidity and need more ventilatory support during the 
first week after birth than female infants (3,7). Male infants are intubated more frequently 
during the first 24 hours of life and receive the first dose of surfactant earlier than female 
infants (3). These preterm male infants are more likely to develop chronic lung disease (2). 
Although mothers carrying male infants received antenatal steroids more frequently 
compared with mothers carrying female infants, male infants are more often in need of 
supplemental oxygen at early gestational age (3). The underlying mechanisms to why male 
sex is associated with increased neonatal mortality and morbidity is still unknown. 
Previous studies have shown that surfactant increases earlier in gestation in female than 
in male neonatal lungs (8-11). This may contribute to the higher airflow rate and lower 
airway resistance in female neonatal lungs compared with male neonatal lungs (8). 
Although female lungs tend to be smaller and weigh less than male lungs, the number of 
alveoli per area do not differ (8,12). Animal studies support a role for sex hormones in the 
regulation of lung development (8,9). Androgens inhibit fetal lung surfactant production 
(9,13) whereas estrogens stimulate alveolar development (9,14). 
 
The majority of extremely preterm births (24–26 weeks) are associated with 
chorioamnionitis (15,16), and it is mainly in this age group that sex differences are most 
evident. Chorioamnionitis is a well-known modulator of both short-term and long-term 
pulmonary outcomes after preterm birth (17-21). A sex difference in susceptibility for 
chorioamnionitis-associated adverse outcomes may explain part of the discrepancy 
between male and female outcomes after preterm birth. However, we are unaware of any 
clinical studies that have evaluated a possible interaction between chorioamnionitis and 
sex with regard to neonatal pulmonary outcome among preterm infants. We therefore 
hypothesized that chorioamnionitis would differentially affect lung injury as well as lung 
maturation based on sex. To test this hypothesis we evaluated the effect of experimental 
chorioamnionitis between male and female fetal sheep delivered prematurely for markers 
of inflammation in bronchoalveolar lavage fluid (BALF) and cord blood as well as 
pulmonary pressure-volume curves and lung histology as a proxy for lung maturation. 
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Methods 
Animal Model 
Pregnant ewes received intra-amniotic injections with 10 mg Escherichia coli 055:B5 
endotoxin (lipopolysaccharide [LPS]) (Sigma, St Louis, Missouri) or saline (controls) at 2 or 
7 days before surgical delivery (Figure 1). At 123 to 125 days of gestation (term is ~147 
days) the lambs were killed without breathing with intravascular pentobarbital. These 
studies were performed during the period 2003 to 2010, and this report is a composite of 
animal groups previously reported (22-30). 
 
C-Section 
124 d GA
2d
7d
7d
# Male       # Female     # Total
17 13 30
18 27 45
32 28 60
67 68 135
2d
IA LPS
IA LPS
IA saline  and/or IA saline
 
Figure 1: Timing of fetal exposure to intra-amniotic (IA) lipopolysaccharide (LPS) indicating the time before 
surgical delivery and number (#) of animals per group. Surgical delivery was performed at 124 days (d) 
gestation. 
 
Pressure-Volume Curve 
After exsanguination of the lambs, the thorax was opened by a midline incision as 
previously described (31). An endotracheal tube was inserted and connected to a 
manometer. The deflation limb of a pressure volume curve was recorded from a 
maximum pressure of 40 cm water. All lung gas volumes are expressed as milliliters per 
kilogram body weight. 
 
Lung Structure Histology 
Paraffin-embedded lung tissue sections from the left upper lobe (4 ʅm, transverse) were 
stained with hematoxylin and eosin. Per section 5 representative microscopic images were 
made with a 10× magnification using a Leica microscope and Leica Qwin Pro version 3.4.0 
software (Leica Microsystems, Mannheim, Germany). The images were uploaded in 
Matlab 6.0 software (The Mathworks, Inc, Natick, Massachusetts). This software 
calculated the alveolar wall thickness (AWT) and mean alveolar size (MAS) for analysis. 
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BALF 
The left lung was lavaged 5 times with ice-cold saline (22). The BALF was pooled and 
centrifuged at 500 rpm for 5 minutes for cytospin preparations. After staining with 
Pappenheim-staining (May-Grünwald, Giemsa) differential cell counts were performed 
(22). 
 
Cord Blood 
Arterial cord blood samples were collected at delivery for complete white blood counts 
(22). Platelets were used as a proxy for systemic inflammation (32). The arterial pH was 
measured in an automated blood gas analyzer (Radiometer, Copenhagen, Denmark). 
 
Statistical Analysis 
Results are given as means (SD). For graphical display, SEM is used in the Figures. 
Comparisons between groups and sex were performed by 2-way ANOVA. Significance was 
accepted at probability value of <0.05. Analyses were performed using SPSS 16.0 (IBM, 
Amsterdam, the Netherlands) and GraphPad Prism 5 (GraphPad Software, Inc, California). 
 
Results 
 
General Characteristics 
General characteristics for each group are shown in the Table. Mean gestational age (SD) 
was 124 ± 1 day. The body weights as well as the lung weights of male lambs were similar 
to that of females (see the Table), indicating similar growth and development. 
Measurement of pH in cord blood showed no differences between males and females. 
 
Table: General physiology characteristics of the study groups. 
* There were no differences between males and females after 2d and 7d exposure to lipopolysaccharide 
† Lung weight is standardized per kilogram body weight 
Treatment * 
Gestational Age (d) Body Weight (kg) 
Male Female Male Female 
Control 123.7 ± 1.1 124.2 ± 1.3 2.78 ± 0.45 2.70 ± 0.47 
2d LPS 123.7 ± 1.0 123.6 ± 1.2 2.66 ± 0.35 2.51 ± 0.32 
7d LPS 124.1 ± 1.1 124.0 ± 1.2 2.73 ± 0.38 2.61 ± 0.44 
     
Treatment * 
Lung weight † (g/kg BW) pH in cord blood 
Male Female Male Female 
Control 35.7 ± 5.4 36.5 ± 5.6 7.28 ± 0.09 7.26 ± 0.12 
2d LPS 40.7 ± 5.4 41.5 ± 4.9 7.24 ± 0.12 7.23 ± 0.10 
7d LPS 36.5 ± 3.8 38.5 ± 7.3 7.30 ± 0.12 7.23 ± 0.14 
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Lung Compliance 
Lung compliance was assessed with lung gas volumes from pressure volume curves as a 
measurement of lung maturation. In the control groups no differences in lung gas volumes 
were detected between male and female lambs (Figure 2A). LPS administered 2 days 
before birth significantly decreased lung gas volume in male lambs compared with 
controls, whereas females were unaffected (Figure 2B). Conversely, LPS administered 7 
days before birth resulted in large increases in lung gas volumes in both sexes relative to 
controls; the females had higher lung gas volumes than the males (Figure 2C). 
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Figure 2: Pressure-volume curves of the lungs of (A) control subjects, (B) sheep fetuses at 2 days gestation, and 
(C) sheep fetuses at 7 days gestation. Significant differences between males and females were present for 
injections 2 days and 7 days of injections with lipopolysaccharide before deliveries. BW = body weight. *P <0.001 
versus male; †P <0.01 versus control; ‡P <0.001 versus control. 
 
Lung Structure 
Lung maturation was also assessed by the analysis of the lung structure (Figure 3). Lung 
structure was analyzed through measurements of AWT (Figure 3A) and MAS (Figure 3B). 
After 2 days LPS exposure differences were measured in female lungs with a decrease of 
MAS and an increase of AWT. Both parameters were not significantly different between 
sexes. 
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Figure 3: Evaluation of lung structure of preterm sheep fetuses. Two parameters were measured: (A) mean 
alveolar size and (B) alveolar wall thickness. No significant differences were detected by sex. LPS = 
lipopolysaccharide. *P <0.05 versus control. 
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Pulmonary Inflammation 
Leukocytes were greatly increased in BALF after exposure to LPS at the different time 
points (Figure 4). LPS administered 2 days and 7 days before birth increased both total 
number of white blood cells and neutrophils compared with controls (Figures 4A and 4B). 
Monocytes were increased after 2-day LPS exposure (Figure 4C). No differences in 
lymphocytes were detected after LPS exposure compared with controls (Figure 4D). 
Although total white blood cell count, as well as the number of neutrophils and 
monocytes, tended to be higher in males after LPS, no significant differences were 
present. 
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Figure 4: Inflammatory cells in bronchoalveolar lavage fluid, differentiated for (A) total cells, (B) neutrophils, (C) 
monocytes, and (D) lymphocytes (in this panel, the y-axis was adjusted for the low number of lymphocytes). No 
significant differences were detected by sex. LPS = lipopolysaccharide. *P <0.05 versus control. 
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Blood Cells in Cord Blood 
Platelets and total numbers of white blood cells increased significantly after 7 days of 
exposure to LPS in both sexes, but without any differences by sex (Figure 5A and 5B). 
Especially, cord blood neutrophils increased significantly 7 days after LPS exposure in both 
sexes, whereas monocytes were increased only in males (Figure 5C and 5D). No 
differences for neutrophils, monocytes, and lymphocytes were recorded between sexes 
after LPS exposure (Figures 5C, 5D, and 5E). 
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Figure 5: Systemic inflammation measured in cord blood, differentiated for (A) platelets, (B) total cells, (C) 
neutrophils, (D) monocytes (in this panel the y-axis was adjusted for the low number of monocytes), and (E) 
lymphocytes. No significant differences were detected by sex after lipopolysaccharide (LPS) exposure 2 days and 
7 days before deliveries. *P <0.05 versus control. 
 
Discussion 
 
Although many studies have focused on effects of antenatal exposure to inflammation on 
outcome after preterm birth, we are unaware of any previous studies evaluating a 
potential modulatory effect of sex. In our study we observed larger improvements in lung 
compliance after LPS-induced intrauterine inflammation among preterm female fetuses 
compared with males. We did not detect any potentially underlying differences in 
pulmonary and systemic markers of inflammation in these animals. No sex differences in 
either lung compliance or inflammatory responses were present in control animals 
delivered at the same gestational age. 
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We studied sex differences in response to chorioamnionitis at extremely preterm 
gestational age with severe surfactant deficiency because the female survival advantage is 
most evident at this stage for human beings (33). Furthermore, extremely preterm infants 
are at the highest risk of being exposed to chorioamnionitis (15,16). A maturational 
response of the lung to antenatal inflammation is well described in several animal models 
(34-36) and corresponds with the decrease in respiratory distress syndrome generally 
observed in chorioamnionitis-exposed infants (15,37). In our animal model a decrease in 
lung compliance was detectable 2 days after intrauterine LPS exposure only in male 
fetuses. Conversely, lung compliance was enhanced 7 days after LPS, when again lung 
compliance was better in female than in male fetuses. We propose that these differences 
may explain at least part of the female advantage in survival as well as in outcome among 
survivors after preterm birth. The finding that sex differences were only present after LPS 
exposure suggests that chorioamnionitis could well be an important modulator of this 
female advantage among preterm infants. To examine the mechanism behind this female 
advantage we analyzed the lung structure for differences in alveolar size and wall 
thickness. However no sex difference in MAS and AWT was noticed. This suggests that the 
female advantage in lung gas volume is not based on lung histology. This outcome 
contributes to the theory that not the lung structure but the surfactant deficiency in male 
lungs might play a key role in the female advantage after preterm birth. Further 
investigations in existing and future human cohorts are required to test this proposed 
mechanism between sexes. 
In our study we assessed pulmonary as well as systemic markers of inflammation to 
determine their potential mechanistic role in the observed sex differences in lung 
compliance. The absence of major differences in these markers suggests that other 
mechanisms may primarily be involved. 
Lung maturation as an effect of antenatal steroid exposure is well recognized, and fetal 
stress and cortisol release have been proposed as potential modulators of the pulmonary 
maturational response to inflammation (38,39). In previous studies (40,41) it was 
demonstrated that sex-specific differences in the cortisol stress response are indeed 
present before birth after a hypoxic event. However, the cortisol response was found to 
be much greater in male than female fetuses, theoretically putting males at an advantage 
with regard to lung maturation. Furthermore, we previously showed in fetal sheep that 
fetal plasma cortisol concentrations significantly increased after intra-amniotic LPS, but 
that this increase in fetal cortisol was not sufficient to cause preterm lung maturation (42). 
These findings do not support a primary role for differential corticosteroid-induced 
responses by sex in mediating pulmonary maturational differences. In addition, a study 
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about the number and binding affinity of lung glucocorticoid receptor showed no 
significant difference by sex (43). 
 
Previous studies have pointed toward a potential role for sex-hormones in sex differences 
during lung development. Androgens inhibit fetal lung surfactant production by 
downregulation of epidermal growth factor receptor activity and upregulation of 
transforming growth factor-ɴ receptor activity (9,13). Surfactant deficiency is a major 
contributor to the development of respiratory distress syndrome in preterm infants. 
Indeed surfactant production has been demonstrated to appear earlier in gestation in 
female compared with male neonatal lung (10,11). 
In addition, interleukin 1 (IL-1) has a central role in the pathogenesis of chorioamnionitis-
induced fetal inflammatory responses. Increased levels of cord IL-1 receptor antagonist 
(IL-1ra) were associated with adverse outcome in preterm infants (44). Interestingly, these 
levels were higher in female than in male fetuses. Although sex differences in IL-1ra 
concentrations may in part explain the lower susceptibility of female fetuses to infection 
(45), our model did not provide much evidence that a sex-specific immune response is 
involved in the pulmonary maturational response to chorioamnionitis. 
 
To our knowledge no studies have investigated long-term effects of chorioamnionitis on 
lung maturation by sex. Recent investigation of the long-term effects of LPS injections in 
utero demonstrated recovery of structural changes and recovery of the immune system 
(35), but no analysis of sex effects was performed. 
Our study has several limitations. We cannot rule out a modulatory effect of sex on 
inflammatory responses that could underlie pulmonary maturational responses, based on 
inflammatory cell numbers alone. Additional inflammatory markers may reveal 
differences. The findings reported here were from multiple experiments performed with 
other primary objectives, but performed with the same type and source of LPS, the same 
breed of sheep, and under similar experimental conditions. However, we cannot exclude 
variations between experiments occurred over this time frame. Strength of the study is 
the large animal population available for analyses. 
 
Conclusions 
 
Female sheep fetuses exposed to intra-amniotic LPS have increased lung gas volumes 
when compared with male sheep fetuses. These results highlight important sex 
differences in the pulmonary response to chorioamnionitis that may explain at least part 
of the female advantage in outcome after preterm birth. 
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Abstract 
 
Background: Animal models should display important characteristics of the human 
disease. Sheep have been considered particularly useful to study allergic airway responses 
to common natural antigens causing human asthma. A rationale of this study was to 
establish a model of ovine precision-cut lung slices (PCLS) for the in vitro measurement of 
airway responses in newborn and adult animals. We hypothesized that differences in 
airway reactivity in sheep are present at different ages. 
 
Methods: Lambs were delivered spontaneously at term (~147 days) and adult sheep lived 
till 18 months. Viability of PCLS was confirmed by the MTT-test. To study airway 
provocations cumulative concentration-response curves were performed with different 
allergic response mediators and biogenic amines. In addition, electric field stimulation, 
passive sensitization with house dust mite (HDM) and mast cells staining were evaluated. 
 
Results: PCLS from sheep were viable for at least three days. PCLS of newborn and adult 
sheep responded equally strong to methacholine and endothelin-1. The responses to 
serotonin, leukotriene D4 and U46619 differed with age. No airway contraction was 
evoked by histamine, except after cimetidine pretreatment. In response to EFS, airways in 
PCLS from adult and newborn sheep strongly contracted and these contractions were 
atropine sensitive. Passive sensitization with HDM evoked a weak early allergic response 
in PCLS from adult and newborn sheep, which notably was prolonged in airways from 
adult sheep. Only few mast cells were found in the lungs of non-sensitized sheep at both 
ages. 
 
Conclusion: PCLS from sheep lungs represent a useful tool to study pharmacological 
airway responses for at least three days. Sheep seem well suited to study mechanisms of 
cholinergic airway contraction. The notable differences between newborn and adult sheep 
demonstrate the importance of age in such studies. 
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Introduction 
 
The prevalence of asthma increased during the last decades (1,2) and may be related to 
Western lifestyle factors (2,3). However, the causal reasons and underlying mechanisms 
are not well understood. Several studies have shown that in most cases of persistent 
asthma, the initial asthma-like symptoms occur during the first years of life (4,5). It has 
been suggested that the child’s environment plays an important role to develop asthma 
later in life. Children exposed to a farm environment had less asthma and atopy than 
children grown-up in a non-farming setting (6-9). The mechanism associated with this 
protective effect is unknown. It is suggested that the child’s immune system may be 
stimulated along a Th1 pathway by early exposure to increased concentrations of bacterial 
components present in stables such as endotoxin (lipopolysaccharide [LPS]) (10). This 
theory is known as the hygiene hypothesis (11). For some of these children asthmatic 
symptoms seem to remit with time, but many children develop asthmatic symptoms 
which persist throughout their life and are associated with more severe symptoms ending 
in the loss of lung function. About 15% of the wheezing infants develop persistent 
wheezing and clinical asthma later in life (12).  
Animal models of asthma should display the pathology of the human disease and have 
carefully to be selected. Several studies indicate for instance that the innervation of the 
lung differs considerably between and within species (13,14). Moreover, rodent airways 
do not or only weakly respond to leukotrienes (15), mediators that readily cause 
bronchoconstriction in humans (16) and guinea pigs (17). Sheep show a greater 
resemblance to humans concerning lung development compared to rodents. Rodents and 
guinea pigs undergo the alveolar phase of lung development postnatal whereas sheep and 
humans undergo this phase in the uterus (18-20). In addition sheep can, like rodents, be 
sensitized to house dust mite (HDM) antigen which is a common human antigen in 
asthma, and have allergen-specific IgE responses and acute eosinophil responses to 
allergen challenge (21,22). Therefore, sheep have been considered particularly useful as 
models to study allergic airway responses to common human natural antigens. 
Airway responses can be visualized by precision-cut lung slices (PCLS), which are viable 
lung tissue slices of uniform thickness (у250 µm). PCLS can easily be prepared from 
different species and are already established for many species including rat, mouse, 
guinea pig, non-human primates and humans (14,17,23-26). PCLS represent a highly useful 
model to study bronchial and pulmonary vascular responses by videomicroscopy (23,27). 
The responses in pulmonary vessels strips of newborn and adult sheep have shown 
interesting differences in reactivity (28). The diameter of the pulmonary vessels increased 
from the newborn to the adult animals and the maximum velocity of shortening was in 
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newborns much higher than in adult sheep. The responses of airways in newborn and 
adult sheep have not yet been investigated. We hypothesize that differences in airway 
smooth muscle reactivity in sheep are present at different ages.  
In the present study the bronchoconstriction of newborn and adult sheep was studied in 
PCLS. A rationale of this study was to establish a model of ovine PCLS for the 
measurement of airway responses to early allergic response mediators and to allergens 
(after passive sensitization) in newborn and in adult animals. 
 
Materials and Methods 
 
Animal model 
All animal procedures were approved by the Animal Ethics Committee of the University of 
Maastricht, The Netherlands. The newborns (n=7) were delivered spontaneously at term 
(147 ± 2 days GA). The lambs were euthanized directly after surgical delivery with an 
intravenous injection of pentobarbital. Adult sheep (n=5) were euthanized at ~18 months 
with pentobarbital. 
 
Preparation of PCLS 
PCLS were prepared from adult or newborn sheep lung as described in previous studies 
(14,17,23-25) with some modifications. Briefly, the lungs were filled via the lobular 
bronchus with 1.5% low-melting-point agarose solution and put onto ice until the agarose 
had solidified. Tissue cores (1 cm in diameter) with a penetrating airway were punched 
out. Those cylinders were then cut perpendicular to the airway by means of a Krumdieck 
tissue slicer (Alabama Research and Development, Munford, AL, USA) into approximately 
250 ʅm thin PCLS. PCLS were transferred into a 10 cm cell culture dish and incubated 
under cell culture conditions (37°C, 5% CO2 atmosphere) in minimal essential medium 
(MEM) that was frequently changed during the next 4 hours (h) and incubated overnight. 
The medium exchange supported the removal of tissue released mediators as well as the 
wash out of agarose from airways. For measurements, only slices with airways free of 
agarose, with beating cilia and an intact and relaxed airway smooth muscle layer were 
used. We only studied PCLS with comparable airway size in parallel experiments to reduce 
interslice variations. Electric field stimulation (EFS) on PCLS and passive sensitization 
studies were performed within 24 h after preparation. All other physiological 
measurements were conducted within 48 h after preparation. 
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Viability of PCLS 
Viability of PCLS over three day incubation was confirmed by intracellular reduction of a 
tetrazolium dye to its according purple formazan (MTT-test) and constriction responses. 
PCLS were transferred into cavities of a standard 24оwell plate (1 PCLS/well) and 
incubated with 900 µL MEM + 100 µL 3о(4,5оdimethyl-thiazolоϮоyl)о2,5оdiphenyl 
tetrazolium bromide solution (MTT, 7 mg/mL) for 15 min. The supernatant was discarded 
and the formazan was dissolved by incubation of PCLS with 200 µL formic acid/propanol 
(5%/95%) solution for 20 min. 100 µL of the purple supernatant were taken and 
transferred to 96оwell plates to measure the exƟncƟon at 550 nm (Tecan GENios 
Microplate Reader). All reactions were carried out at room temperature and in the dark. 
For negative control measurements PCLS were digested with 0.2% (v/v) TritonоX100 (300 
µL, 20 min, 37°C) before performing the MTTоassay. 
 
Videomicroscopy 
If not otherwise stated, PCLS were kept in cavities of standard 24-well plates and were 
immersed in 1 mL MEM during the experiment. The plate was then mounted on the stage 
of an inverted Leica DMIL microscope (Leica Microsystems, Wetzlar, Germany). The 
airways were imaged and digitized by videomicroscopy (SensiCam 365KL digital camera, 
Visitron Systems, Munich, Germany; Optimas 6.5 software, Optimas, Bothell, WA, USA). 
The airway area before any provocation was defined as 100%оiniƟal airway area [%оIAA]. 
 
Airway provocations by early allergic response mediators and biogenic amines 
Cumulative concentration-response curves were performed with methacholine (10о10 M о 
10о4 M; 5 min/conc.; pictures every 5 s), serotonin (10о10 M о 10о4 M; 5 min/conc.; pictures 
every 5 s), histamine (10о9 M о 10о4 M; 5 min/conc.; pictures every 5 s), endothelin-1 (10о12 
M о 10о6 M; 10 min/conc.; pictures every 10 s), leukotriene D4 (LTD4, 10
о12 M о 10о6 M; 10 
min/conc.; pictures each 5 s) and the thromboxane A2 analogue U46619 (10
о10 M о 10о5 M; 
10 min/conc.; pictures every 5 s). To study a potential effect of the histamine H2-receptor 
on bronchoconstriction, PCLS were pre-incubated with 10 µM cimetidine for 15 min prior 
to performing the histamine concentration-response curve. 
 
Electric field stimulation (EFS) 
As described before (29), EFS of PCLS was carried out in standard 12-well plates at a 
reaction volume of 1 mL standard MEM. The PCLS were placed in between two platinum 
electrodes of 12 mm distance and were mounted by a Teflon ring. The electric field was 
applied by a Hugo Sachs Electronics Stimulator II (Hugo Sachs Electronics, March 
Hugstetten, Germany). The electric stimuli were defined by a frequency of 50 Hz, pulse 
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duration of 1 ms, a current amplitude of 200 mA, a train width of 2.5 s and a train rhythm 
of 60 s. Each train lasted 3.3 min. After the first control stimulation the muscarinic 
antagonist atropine (10 ʅM) was added and incubated for 15 min prior to the second 
stimulation. In an additional set of EFS experiments, frequency response curves were 
conducted on PCLS from adult and newborn sheep. In this, the frequency was steadily 
increased from 0.4 Hz – 100 Hz, while the pulse duration and current amplitude were kept 
constant at 1 ms and 200 mA, respectively. Each frequency was applied once for 2.5 s and 
after a pause of one minute the next frequency was applied. The airway behavior of PCLS 
upon stimulation was monitored by videomicroscopy. Pictures were taken every 2.5 s. 
Airway area before the first stimulation was defined as 100% initial airway area (IAA). 
 
Passive sensitization 
Passive sensitization was performed by incubation with 1% serum from house dust mite 
(HDM)оsensiƟzed sheep overnight. Medium was replaced by fresh serumоfree MEM 
directly before provocation with 5000 Units of HDM from ALKоSHERAX (Wedel, Germany), 
which is normally used for intracutaneous testing of atopy. Airway responses were 
followed by videomicroscopy for 20 min. Pictures were taken every 10 s and pruned for 
clarity to each fifth data point. 
 
Mast cell staining 
Mast cells were stained with toluidine blue or with alcian blue and safranin. Briefly, PCLS 
were fixed with formaldehyde 4% (Roti®оHistoĮx 4%, Carl Roth GMBH & Co. KG, Karlsruhe, 
Germany), dehydrated and embedded in paraffin. Then, 5 µm thick sections were cut, 
deparaffinized, rehydrated and incubated in 1% toluidin blue for 30 min. After rinsing with 
water, sections were dehydrated and coverslipped. Alternatively after rehydration, 
sections were incubated in 0.05% Alcian Blue in 0.02 M acetate buffer, pH 5.8 with 0.2 M 
MgCl for 4h. After rinsing in water, sections were incubated for 5 min in 0.25% safranin 
0.02 M acetate buffer, pH 5.0. After a final rinsing step, sections were dehydrated and 
coverslipped. 
 
Data analysis 
Data are shown as means ± standard error of the mean (SEM). Concentration-response 
curves were fitted by non-linear regression (4оparameter logisƟc equaƟon). To analyze 
differences between curves, each parameter of the 4оparameter logistic equation was 
separately compared by the Extra sum-of-squares F-test. The 4-parameter logistic 
equation is [Y=Bottom + (Top-Bottom)/(1+10^((logEC50-X)*HillSlope)], with the bottom 
being the maximal response (i.e. fit values aim towards the minimum in the concentration 
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response curves), the top being the initial situation (i.e. fit values aim towards 100%-IAA), 
the logEC50 being calculated to the half maximal response and the slope initially kept 
variable (i.e. unconstrained from a standard value of 1). A shared concentration-response 
curve was plotted for adult and newborn sheep, if no difference was found in any 
parameter of the 4оparameter logisƟc equaƟon. Minimal airway areas in EFS before and 
after atropine treatment were compared by Student‘s tоtest (due to homogeneity of 
variance). Mixed model analysis considering changes in airway area dependent on time 
and treatment was performed on time courses in the passive sensitization experiments. P-
values <0.05 were considered significant. The statistical analysis was performed by either 
GraphPad Prism 5 (GraphPad Software, La Jolla, CA) or SAS 9.1 (SAS Institute Inc., Cary, NC). 
 
Results 
 
Viability of PCLS 
More than 50 slices were obtained from one lung lobe of either newborn or adult sheep. 
The viability of sheep PCLS was demonstrated by the MTT test and PCLS were viable for at 
least three days (Figure 1). In Figure 1A, high extinctions in this test indicate intact cellular 
reduction systems, which correlate to viability. PCLS of adult sheep had an extinction OD 
of 0.2 stable over 3 days compared to deterged control PCLS with an extinction OD of 
0.05. PCLS of newborn sheep had also a robust extinction OD of up to 0.3 over 3 days. 
Functionality of airway smooth muscle contraction was shown by the application of 10о4 
M methacholine, which evoked a strong bronchoconstriction in sheep PCLS (Figure 1BоC). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Viability of sheep PCLS. (A) 
Viability was followed by the MTT test. 
High extinctions indicate high viability. 
Data are shown as mean ± SEM, n= 3 PCLS 
from 3 animals per group.  
Exemplary photographs (in black and 
white) of a PCLS before (B) and after (C) 
provocation with 10-4 M methacholine. 
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Airway provocations by allergic response mediators or biogenic amines in adult and 
newborn sheep 
In sheep PCLS all of the mediators of the early allergic response in humans, except for 
histamine, evoked a marked bronchoconstriction (Figure 2AоF). In general, concentraƟon-
response curves are characterized by their efficacy and potency. Shared concentration-
response curves in PCLS from adult and newborn sheep were found for methacholine and 
endothelin-1 with half-maximal responses (logEC50 [M]) of -7.0 ± 0.1 and -7.7 ± 0.1, 
respectively (Figure 2A and 2D). 
Age related differences in potency were found for serotonin and LTD4. For serotonin the 
logEC50 [M] values were -6.3 ± 0.4 for newborn and -6.9 ± 0.2 for adult sheep (Figure 2B), 
whereas for LTD4 logEC50 values were smaller for newborn than for adult sheep (-9.7 ± 0.4 
[M] vs. -8.0 ± 0.6 [M]) (Figure 2E). Differences in efficacy were found for U46619, as 
airways of adult sheep responded markedly to U46619 (logEC50 [M] = -5.9 ± 1.0; max 
contraction to 64.6 ± 8.4%оIAA at 10о5 M), whereas airways of newborn sheep were 
mostly unresponsive (max. contraction to 93.4 ± 6.5%оIAA at 10о5 M) (Figure 2F). 
 
Airway provocation by histamine with or without cimetidine 
Since in the preceding experiments no airway contraction was observed by histamine, 
PCLS were pretreated with or without cimetidine, which blocks the H2оreceptor. Again, 
airways in control PCLS, i.e. without cimetidine, did not contract in adult sheep (Figure 3). 
In contrast, stimulation of airways in PCLS with histamine after cimetidine pretreatment 
resulted in a marked concentration-dependent contraction (logEC50 = -6.3) (Figure 3). No 
data were available for PCLS from newborn sheep. 
 
Intrinsic activation of bronchoconstriction in sheep PCLS 
In addition to the preceding exogenous activation of bronchoconstriction in PCLS by 
exogenous application of mediators, we studied whether an intrinsic activation of airway 
response is possible in sheep PCLS. In this regard, two approaches were chosen: EFS to 
study neutrally-induced bronchoconstriction and passive sensitization to evoke an early 
allergic response by mast cell degranulation after antigen challenge. In response to EFS, 
PCLS from both adult and newborn sheep, strongly contracted to 43.7 ± 13.9% IAA and 
34.3 ± 6.5% IAA (Figure 4), respectively. This neurallyоinduced response was potently 
blocked by atropine resulting in an airway contraction to only 84.0 ± 7.6% IAA for PCLS 
from adult sheep and 78.6 ± 6.8 for PCLS from newborn sheep. Moreover, to distinguish 
between a difference in sensitivity of PCLS from newborn and adult sheep to EFS, 
frequency response curves were conducted. However, a shared curve was found (Figure 4 
C), indicating equal sensitivity of PCLS from newborn and adult sheep to neural 
stimulation. 
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Figure 2: Concentration-response curves for common mediators of early allergic response in PCLS of adult (z) 
and newborn sheep (). (A) methacholine, (B) serotonin, (C) histamine, (D) endothelin-1, (E) leukotriene D4 
(LTD4), and (F) U46619. n = number of PCLS, whereby a total of 7 newborn and 5 adult sheep were examined. 
Data are shown as mean ± SEM. A shared concentration-response curve was plotted for adult and newborn 
sheep, if no difference was found in any parameter of the 4оparameter logisƟc equaƟon. 
 
 
Figure 3: H2оreceptor counteracts histamine-induced 
bronchoconstriction in adult sheep PCLS. PCLS from adult 
sheep were either pre-incubated with the H2-receptor 
antagonist cimetidine before histamine provocation (z) or 
kept untreated (control,). Data are shown as mean ± SEM, 
n= number of PCLS of separate sheep. The concentration 
response curves were fitted by the 4оparameter logisƟc 
equation. 
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Figure 4: Electric field stimulation (EFS) 
of PCLS from newborn and adult sheep. 
(A) Course of airway area changes 
during repeated EFS in absence or 
presence of atropine. (B) Statistical 
analysis on minimal airway area during 
EFS as obtained in (A), data are shown 
as mean ± SEM, n= 7 for newborn sheep 
and n= 4 for adult sheep, whereby each 
PCLS was taken from an independent 
sheep; *P < 0.05; ***P < 0.001 in 
Student‘s tоtest. (C) Frequency-response 
curves of EFS-induced airway 
contractions. Data are shown as mean ± 
SEM, n= 5 PCLS from three newborn 
sheep and n= 8 PCLS from five adult 
sheep. A shared frequency-response 
curve was plotted for adult and 
newborn sheep, since there was no 
difference in any parameter of the 
4оparameter logisƟc equaƟon assuming 
that the top is equal to 100%-IAA and 
EF50 is larger than zero Hz. 
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With respect to passive sensitization, provocation with 5000 U of HDM evoked a weak but 
significant early allergic response in PCLS from adult and newborn sheep that had been 
incubated with serum from HDM sensitized sheep (Figure 5A and 5B). Comparing the 
HDM-induced airway contractions in PCLS from adult and newborn sheep, a significant 
difference was found in the respective kinetics. The response to HDM was more sustained 
in adult than in newborn sheep. In order to study these responses, we stained for mast 
cells in the lung tissue since we consider them essential for the response. In accordance to 
the weak response, very few mast cells were found in PCLS from sheep at both ages as 
shown in Figure 5C and 5D. We found on average less than one mast cell per 5 µm thick 
section. 
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Figure 5: Early allergic response in sheep PCLS after passive sensitization. PCLS from newborn (A) or adult (B) 
sheep were passively sensitized with serum from actively sensitized sheep against HDM and provoked with 
5000 U HDM. Data are shown as mean ± SEM, n as indicated on PCLS from different sheep. Time courses were 
statistically compared by mixed model analysis; *P < 0.05. Comparing HDM groups in (A) and (B), courses are 
also significant different, which points out differences in the kinetics of allergen-induced bronchoconstriction in 
adult and newborn sheep. Panels (C) and (D), less than one mast cell per 5 µm thick section was found in PCLS 
from sheep. PCLS were stained for mast cells with toluidine blue (C, arrow) or with alcian blue and safranin (D). 
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Discussion 
 
To our knowledge this is the first time, the airway reactivity of newborn and adult sheep 
was compared in PCLS. Many of the responses were similar in newborn and adult sheep, 
such as the bronchoconstriction to EFS, and to the mediators methacholine, histamine and 
endothelin-1. On the other hand different responses in newborn and adult sheep were 
found for the eicosanoids LTD4 and thromboxane as well as the biogenic amine serotonin. 
The response to allergen after passive sensitization was comparable in the extent of 
contraction, but prolonged in adult sheep. 
PCLS are viable, can readily be obtained from different species and offer a great 
opportunity to study airway responses under cell culture conditions (14). The 
microarchitecture of lung tissue, i.e. airways and vessels embedded in the parenchyma, 
remains intact and permit physiological measurements (23-26). Even nerves remain 
functional and can be specifically activated (29). In the past, PCLS from rat, mouse, guinea 
pig, non-human primate and human lung have been investigated (14,26). Allergic 
responses in sheep have been suggested to be similar to humans (18,19,21,22), but the 
response of airways to early allergic response mediators in newborn compared to adult 
sheep had not been investigated yet. Recurrent wheezing is common in young infants and 
toddlers (30). For some of these children asthmatic symptoms seem to remit with time, 
but many children develop asthmatic symptoms which persist throughout their life 
(12,31). Therefore, it is important to compare the allergic responses in newborn to adult 
lung tissue. 
Given the importance of small airways for asthma and COPD (24,25,32,33), the possibility 
to study these airways in PCLS is of clinical relevance. Small airways are defined by their 
inner diameter being less than 2 mm in human (airway generations >11) and less than 780 
µm in rat airways (25,34). Since sheep are comparable in weight to humans, lung/airway 
sizes and generations should correlate to the human structure. In this context of note, the 
current experiments were exclusively performed on small airways, since they were less 
than 2 mm in diameter. Therefore, our results reflect the situation only for the peripheral 
lung reducing interslice variations since airway responses can differ between large and 
small airways (23,29). 
In the present study PCLS from sheep were viable for at least three days, not different 
from the viability of human PCLS (24), making it possible to study the effects of cytokines, 
growth factors and maybe even remodelling processes (35,36). In addition, recent work by 
Behrsing and colleagues (37) has demonstrated that the process of slicing itself elicits a 
massive cytokine response, confounding early results of cytokine measurements in 
response to PCLS challenge. Moreover, in contrast to our study, they also used 
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transcriptionally active agents like humulin, hydrocortisone and retinoic acid in their 
incubation medium. In the current study, we have performed frequent medium exchanges 
during the first 24 h after slicing to minimize the effect of endogenously released 
mediators. Nonetheless in general, the impact of mechanical damage conducted to create 
the PCLS should be noticed when cytokines and mediators are studied in PCLS. 
PCLS of newborn and adult sheep responded very similar to methacholine and endothelin-
1, mediators also effective in humans (17). However, the response to serotonin, the 
thromboxane analogue U46619 and LTD4 depended on the age of the sheep. In newborn 
sheep the response to serotonin and U46619 was weaker than in adult sheep, whereas 
the response to LTD4 was stronger in newborn sheep. This is an important difference 
compared to rodent airways that do not or at best very weakly respond to LTD4 (15). 
Leukotrienes contribute to airway obstruction in many human asthmatics (29). In this 
regard sheep PCLS, in particular newborn, may appear as a suitable animal model to study 
bronchoconstriction. From pharmacological and clinical point of view these results are 
very interesting. The strong bronchial response of newborn sheep to leukotrienes suggests 
that young animals will be more sensitive to the effects of montelukast, which is a 
leukotriene-receptor antagonist and used to prevent the wheezing and shortness of 
breath caused by asthma. On the other hand, in the present study it is demonstrated that 
adult sheep have a stronger bronchial response to serotonin. Therefore, adult sheep may 
be more sensitive to the effects of ketanserin, which is a highly selective antagonist for 
contractile serotonin 5-HT2A receptors. Our studies show a lifetime dependent response 
pattern to different antagonist, which suggest specific disease treatment with different 
antagonist depending on the age of the sheep. 
Compared to human PCLS, there are also differences: sheep airways reacted to serotonin 
rather than to histamine, which is the opposite to what is observed in human and guinea 
pigs PCLS, in which histamine (EC50 2.7mM) is effective but serotonin is not (17,24,25). The 
reason for these species differences is not clear. It was suggested that it may, at least in 
part, be related to age differences in tissue as shown in young healthy guinea pigs versus 
middle-aged adults (17,24,25). However, the present study demonstrated that the 
bronchoconstriction in both newborn and adult sheep was the same and that age 
differences may not play such a crucial role if one compares responses from animal tissue 
with that from human tissue. 
Importantly, however, the lack of responsiveness to histamine was not due to the lack of 
H1-receptors. This was revealed by experiments with the H2-receptor antagonist 
cimetidine (Figure 3), which has also minor affinity for H1-, H3- and H4-receptors (38,39). 
Here, we consider effects of H3 and  H4 activities unlikely, because H3 is predominantly 
expressed in brain tissue and H4 is attributed to immune cell responses (40,41). Moreover, 
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in literature there are no reports about H3 and  H4 expression in sheep lung. Since no 
analysis of the different histamine receptor expression was performed in lung tissue in the 
present study the discussion about H3 and H4 remains speculative and is a clear limitation 
of this study. Normally, in the lungs histamine acts on H1- and H2-receptors and its effect is 
therefore balanced by the H1-mediated contraction and the H2-mediated relaxation of 
airway smooth muscles (42-45). The observation that histamine contracts tracheal and 
bronchial airways, but relaxes smaller bronchi and bronchioles (46), indicates that there is 
a shift towards predominance of H2оreceptors towards the peripheral airways. Thus, the 
present finding that histamine was able to contract ovine airways only after blockade of 
H2-receptors, may reflect the fact that the PCLS were derived from the lung periphery. In 
addition, the expression of histamine H2-receptors in the lungs may also differ depending 
on the type of lung sample, previous sensitization or infection, frequently leading to 
down-regulation of H2-receptors (47-49). Therefore, H2-receptor deficiency in the airways 
may, at least in part, explain the commonly observed airway hyperreactivity to histamine 
in asthmatics.  
In the present study, the early allergic response in passively sensitized sheep PCLS was 
weak. One explanation might be that after degranulation mast cells mainly release 
histamine, which – as seen before – is ineffective unless H2-receptors are blocked. 
Alternatively, this finding can be explained by the small number of mast cells found in the 
airways of PCLS from non-sensitized sheep. It was demonstrated that exposure to HDM 
(active sensitization) doubled the number of mast cells mostly in alveolar septa and in 
airway walls (22,50). Notably, these responses required at least 16 weekly HDM challenges 
(50), while in the present study the sheep lungs were unchallenged and PCLS were only 
passively sensitized with serum from actively sensitized sheep. This might explain the 
small numbers of mast cells in the present study. Another interesting observation in the 
allergen-induced bronchoconstriction after passive sensitization was the prolonged airway 
contraction in PCLS from adult sheep compared to newborn sheep. To our knowledge this 
is the first study examining the early allergic response of adult and newborn animals in 
parallel. Reasons, such as a sustained mediator release, diminished degradation of 
bronchoconstrictors or different receptor density in adult sheep, are therefore 
speculative. Nonetheless, this example confirms, that extreme caution is mandated 
selecting the appropriate animal model, when studying childhood asthma or asthma in 
adults as responses may differ tremendously. 
We further demonstrated that ovine PCLS respond to electric field stimulation. Airway 
responses to electric field stimulation differ largely between species (14). PCLS from rats 
and marmoset airways contract by about 20%, whereas guinea pigs, sheep and humans 
contract at maximum by about 40о60% (14). The present study adds that the maximum 
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contraction (>50%) in both newborn and adult sheep did not differ. Moreover, since the 
sensitivity of sheep PCLS from newborn and adult sheep did not differ, one may speculate 
that the neural network in sheep lung is widely established by birth. The shared 
frequency-response curve is also in line with the exogenous application of methacholine, 
in which also a shared curve, i.e. same sensitivity to the agonist, was found. These findings 
are rounded off by the high atropine-sensitivity of EFS-induced airway contractions 
pointing out that lung innervation in sheep is mostly cholinergic. Hence, airway responses 
in sheep PCLS are a reasonable proxy for human airways, if cholinergic airway contractions 
are intended to study. 
In our model we focused on the acute response to exogenously added inflammatory 
mediators and passive HDM sensitization to demonstrate that ovine PCLS are a reliable 
tool for in vitro measurement of airway responses. It was beyond the scope of this study 
to examine the role of cytokine and mediator secretion in response to a physiologically 
relevant stimulus or active sensitization. In future research it will be relevant to compare 
acute versus chronic responses after HDM sensitization and also to compare HDM to 
sensitization with other allergens. In conclusion, PCLS from sheep lungs represent a useful 
tool to study pharmacological airway responses for at least three days. Sheep seem well 
suited to study mechanisms of cholinergic airway contraction. Their airway pharmacology 
differs in some respects to that observed in humans. Bronchoconstriction is similar in 
newborn and adult sheep, except for the lipid mediators (LTD4, U46619) and serotonin. 
Early allergic response is weak which is probably based on a small number of mast cells. 
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Abstract 
 
Background: We hypothesized that fetal innate immune responses to lipopolysaccharide-
induced chorioamnionitis would alter postnatal systemic immune and airway 
responsiveness. 
 
Methods: Ewes received intra-amniotic injections with saline or lipopolysaccharide at 90, 
100 and 110 days of gestation. Immune status and airway responsiveness were evaluated 
at term and at 7 weeks of age. 
 
Results: At term, lymphocytes, monocytes and neutrophils were significantly increased 
(respectively 24-fold, 127-fold, and 31,000-fold) in lungs and blood monocytes became 
Toll-like receptor 2 responsive after lipopolysaccharide exposures. Furthermore, CD4 and 
CD4/CD25 lymphocytes were increased in thymus and lymph nodes. At 7 weeks, airway 
reactivity decreased and concentrations of CD8 cytotoxic T lymphocytes changed in the 
lungs and thymus relative to controls. 
 
Conclusion: Early gestational lipopolysaccharide exposure increased leukocyte 
responsiveness at term. Decreased airway reactivity and changes in lymphocytes at 7 
weeks postnatal demonstrate persistent effects of fetal exposure to LPS. 
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Introduction 
 
Preterm birth (<37 weeks) is frequently associated with chorioamnionitis (1). Recently, 
chorioamnionitis was correlated with a 4-fold increased risk for developing asthma in 
preterm infants after correction for confounding factors (2-4). This observation is in 
contrast to the hygiene hypothesis (5-7), in which infections during early childhood are 
associated with a decreased risk of subsequent asthma and allergic disease. These 
conflicting observations suggest that the time of exposure to bacterial products during 
childhood may have different effects when compared with antenatal exposures. For 
example, antenatal exposure to bacterial products may increase the risk of asthma in 
childhood, whereas postnatal exposure to bacterial products may protect from asthma. 
The mechanisms to explain the different outcomes are still unclear. 
Chorioamnionitis-mediated inflammation exposes the fetus to proinflammatory mediators 
primarily by fetal breathing and swallowing of amniotic fluid (8-10). The fetal lung 
responds to mediators such as lipopolysaccharide (LPS), interleukin-1 (IL-1), and live 
ureaplasma with a local inflammatory response. Previous experiments revealed that 
exposure to chorioamnionitis changes the lymphocyte population in the posterior 
mediastinal lymph node (PMLN) that drains the lung (11,12) and causes systemic immune 
modulation of blood monocytes (13-15). Furthermore, the gut responses to LPS with 
altered inflammatory cells in the gut wall and regional lymph nodes (8,16). These acute 
fetal responses were modulated further with repeated exposure to induce LPS-tolerance 
and cross-tolerance to other proinflammatory Toll-like receptor (TLR) agonists (13-15). 
However, the relationship between exposure to antenatal inflammation and postnatal 
disease is confounded by gestational age and neonatal lung disease in human studies. 
We hypothesized that fetal innate immune responses to LPS-induced chorioamnionitis 
would alter postnatal systemic immune and airway responsiveness resembling asthma 
later in life. To test this hypothesis, we evaluated immune status at birth and at 7 weeks 
after LPS-mediated chorioamnionitis. We evaluated leukocytes in the bronchoalveolar 
lavage fluid (BALF). Transforming growth factor-beta 1 (TGF-ɴ1) and elastin were 
measured in lung tissue. CD4, CD8, CD4/CD25 and gamma-delta subpopulations of T 
lymphocytes were measured in the PMLN and thymus. Monocytes isolated from blood 
were tested in vitro for responses to LPS and PamCysK4 (a ligand for TLRs 1 and 2). The 
immunologic measurements were performed at term and at 7 weeks of age and airway 
reactivity to methacholine (MCh) was tested at 7 weeks after inhalation of house dust 
mite (HDM). 
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Materials and Methods 
Antenatal treatment 
All animal procedures were approved by the Animal Ethics Committee of the University of 
Western Australia, Australia. Ewes received intra-amniotic (IA) injections with saline 
(controls) or 10 mg Escherichia coli 055:B5 endotoxin (LPS; Sigma-Aldrich, St.Louis, MO) at 
90, 100, and 110 days of gestation (Figure 1). At 147 days of gestation, lambs from LPS 
(n=5) and control (n=3) groups were delivered surgically to assess immune function of the 
fetus at term (term is ~147 days). The remaining ewes delivered spontaneously and airway 
responsiveness and immune status of lambs were evaluated at 7 weeks (LPS n=5, Control 
n=6). Lambs were killed with intravascular pentobarbital at term and at 7 weeks. 
 
 
 
Figure 1: Timing of fetal exposure to LPS. Open arrows indicate gestational age of intra-amniotic (IA) injections 
with LPS or saline. Sheep model with LPS-induced chorioamnionitis. Operative delivery was performed at 147 
days gestation for some animals (n=3-5 lambs), whereas the remaining ewes (n=5-6) delivered spontaneously 
and their lambs were studied at 7 weeks. Immune status was evaluated in postmortem tissues at 147 days and at 
7 weeks. LPS, lipopolysaccharide. 
 
Airway reactivity 
At 7 weeks lambs were sedated 2 days after HDM exposure (nebulized 1 mg) with 
diazepam 0.25 mg/kg (Sigma NSW, Australia) and ketamine 5 mg/kg (Parnell Laboratories, 
NSW, Australia). They were intubated with a 6.0 mm ID tracheal tube (Portex Ltd, UK) and 
ventilated (Humming V, Metran, Japan) with a peak inspiratory pressure of 25 cm H2O, an 
inspiratory time 0.7 second and a rate of 40 breaths per minutes.  A continuous infusion of 
intravenous Propofol (0.3-0.6 mg/kg/h, Repose, 0.1 mg/kg/min, Norbrook Laboratories 
Ltd., Victoria, Australia) and Remifentanil (0.3 mg/kg/h, Ultiva 0.05 ʅg/kg/min; 
GlaxoSmithKline, Victoria, Australia) was commenced, and following confirmation of deep 
anaesthesia, neuromuscular blockade was achieved with vecuronium (0.1 mg/kg IV; Essex 
Pharma, Germany). Lambs were stabilized for 10 minutes before baseline measurements, 
and then received for 1 minute aerosols (1 mL) at 5 minute intervals of saline, followed by 
increasing concentrations (0.01%, 0.03%, 0.1%, 0.3%, 1%; w/v) of methacholine (Acetyl-ɴ-
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methylcholine chloride; Sigma). Partitioned respiratory impedance (Zrs) was measured 
using the low-frequency forced oscillation technique (LFOT) using the FlexiVent (Module 5; 
Scireq, Montreal, Canada). After airway occlusion at commencement of expiration, 
respiratory system input impedance (Zrs) measurements were obtained using a primewave 
(17 mutually prime frequencies from 0.5-19.75 Hz) over a 6-second apneic interval. 
Measurements were repeated every 30 seconds until peak response was observed 
(normally approximately 3 minutes). 
Measurements of pressure and flow were transformed to the frequency domain and 
corrected for the impedance of the tracheal tube and measurement system. The 
partitioned airway (airway resistance - Raw; airway inertance - Iaw) and tissue mechanical 
variables (tissue damping – G; tissue elastance - H) were determined by fitting the 
resultant impedance spectrum to the constant phase model (17). Hysteresivity (ɻ) was 
calculated as G/H. Changes in airway and tissue variables were expressed relative to 
measurements obtained at baseline. 
 
Bronchoalveolar lavage 
After collection of the lungs, thymus and the PMLN, the left lung was lavaged 3 times with 
0.9% NaCl (18). The BALFs were pooled and centrifuged at 500 rpm for 5 minutes. 
Differential cell counts were performed on cytospin preparations after staining with 
Pappenheim-staining (May-Grünwald, Giemsa) (18). 
 
Lung tissue 
Lung tissue from the right lower lobe (RLL) was snap frozen and stored at -80°C. For 
homogenization, a mix of lysis buffer (RIPA buffer, Sigma) and protease inhibitor (Sigma) 
was added to lung tissue. The lung tissue was homogenized (PRO Quick Connect 
Generators part no. 02-07095; PRO Scientific Inc., Oxford, CT) and centrifuged at 12 rcf 
(11.4 rpm) for 5 minutes at 4°C. 
 
Enzyme-linked immunosorbent assay of TGF-ɴ1 
Free, bound, and total TGF-ɴ1 (referred to R&D enzyme-linked immunosorbent assay 
[ELISA] kit; Minneapolis, MN as active, latent and total TGF-ɴ1) were measured with R&D 
ELISA kits (DuoSet ELISA, human TGF/ɴ1, no. DY240; R&D Systems). Free TGF-ɴ1 was 
measured for the original sample. Total TGF-ɴ1 was measured after acid activation of 150 
µL of the sample with 30 µL 1 M HCl for 10 minutes at room temperature and 33 µL 1 M 
NaOH HEPES was used to stop the activation (19). Bound TGF-ɴ1 was calculated as the 
difference between total TGF-ɴ and free TGF-ɴ1. 
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Elastin staining 
We measured elastin foci of secondary crests (concentrated vs. non-concentrated) and 
elastin fiber deposition in the vessel walls. Elastin fibers were stained black with a Hart’s 
resorcin fuchsin solution (20-22), using paraffin slides that were dehydrated and stained at 
60°C and counterstained with a tartrazine solution. A magnification of 200x was used to 
save 3 pictures randomly. Counting of elastin foci was blinded, using ImageJ 1.41o 
software (Rasband; National Institutes of Health, Bethesda, MD) for quantification. 
 
Flow cytometry 
Single cell suspensions of thymus and PMLN were made with a strainer, assessed for 
viability, and counted using a Neubauer chamber (Hawksley, England) (23). The 106 cells 
were incubated with primary monoclonal antibodies (mAbs: CD4, CD8, CD25 and TcR-1 
receptor [gamma-delta T lymphocytes]; VMRD USA) for 30 minutes at 4°C. Cells were 
washed and incubated with fluorescence-conjugated secondary mAbs for 30 minutes at 
4°C in the dark (FITC and R-PE labeled antibodies from SEROTEC, Great Britain). Cells were 
analyzanaled on a FACScalibur instrument (Becton Dickinson, Franklin Lakes, NJ) using 
CellQuest software (Becton Dickinson). CD4/CD25 percentages are expressed relative to 
the population of cells expressing CD4. Other lymphocyte percentages are expressed 
relative to the total population of thymic lymphocytes (11). 
 
Hydrogen peroxide assay for blood monocytes 
Monocytes and macrophages were isolated with Percoll gradients from cord blood (at 
term) and peripheral blood (at 7 weeks) to perform functional tests (15). In brief, the 
isolated cells were cultured in RPMI 1640 media supplemented by 10% heat-inactivated 
fetal calf serum for 6 hours with LPS (a ligand for TLR4; 100 ng/mL; E. coli O55:B5; Sigma-
Aldrich) and PamCysK4 (a synthetic ligand for TLRs 1 and 2; 5 µg/mL; EMC Microcollection, 
Tuebingen, Germany). PamCysK4 signals through the TLR2 pathway and is involved in 
maturation of the immune system. Control cells were exposed to saline (media). After 
washing the cells with phosphate buffered saline (PBS), the production of hydrogen 
peroxide by 1 X 106 monocytes was measured with an assay based on the oxidation of 
ferrous iron (Fe2+) to ferric iron (Fe3+) by hydrogen peroxide under acidic conditions 
(Bioxytech H2O2-560 assay; OXIS International, Portland, OR) (13,15). 
 
Statistical analysis 
Microsoft Excel and GraphPad Prism 5 were used for statistics. Data are shown as mean ± 
SEM. Statistical differences between LPS and control groups were evaluated with Student 
t test and the Mann-Whitney test. Values were considered significant if Pч 0.05 versus the 
control (saline) group. 
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Results 
 
Body and organ weights at birth and at 7 weeks of age 
The body weights of LPS-exposed lambs were similar to the control group at term and at 7 
weeks (table 1) indicating similar growth and development. The organ weights (PMLN, 
thymus, spleen, total lung) were not different for the groups at birth or at 7 weeks of age. 
 
Table 1: Physiology. 
 
Antenatal 
treatment 
Body weight, 
kg 
PMLN, 
g/kg 
Thymus, 
g/kg 
Spleen, 
g/kg 
Total lung, 
g/kg 
n 
At 
Term 
Control 5.0 ± 1.0 0.13 ± 0.01 2.07 ± 1.07 1.37 ± 0.18 35.3 ± 3.3 3 
LPS 5.5 ± 1.0 0.21 ± 0.02 3.59 ± 0.43 1.74 ± 0.20 31.8 ± 2.4 5 
7 
weeks 
Control 16.2 ± 1.3 0.23 ± 0.02 2.52 ± 0.19 4.20 ± 0.30 12.9 ± 0.4 6 
LPS 15.5 ± 1.5 0.26 ± 0.02 2.68 ± 0.48 4.62 ± 0.50 13.7 ± 0.4 5 
 
 
Body weight, organ weights, and number of animals studied at birth and at 7 weeks of age. Organ weights are 
standardized per kilogram body weight. There were no differences to corresponding control group. LPS, 
lipopolysaccharide; PMLN, posterior mediastinal lymph node; n, number of animals. 
 
Table 2: Ventilatory variables of lambs during methacholine challenge. 
 
Treatment 
PaO2, 
mm Hg 
PaCO2, 
mm Hg 
RR, 
breaths/min 
PIP, 
cm H2O 
HR, 
bpm 
Saline (7 weeks) 96 ± 4 53 ± 4 26.5 ± 0.5 25.8 ± 1.9 175 ± 12 
LPS (7 weeks) 98 ± 1 51 ± 1 25.1 ± 0.7 26.8 ± 2.3 161 ± 7 
 
 
HR, heart rate; LPS, lipopolysaccharide; PaCO2, arterial carbon dioxide tension; PaO2, arterial oxide tension; PIP, 
peak-inflation pressure; RR, respiratory rate. 
 
 
Airway reactivity 
Measurements with methacholine challenge at 7 weeks, including heart rate, peak 
inspiratory pressure, respiratory rate and blood gas values (PaCO2, PaO2) were not 
different between fetal LPS exposed and control lambs (table 2). Representative 
impedance spectra are shown in Figure 2.  
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Figure 2: Dose response curves to inhaled methacholine. Responses to inhaled methacholine are expressed 
relative to measurements at baseline for 7-week old lambs that were exposed to intra-amniotic injections of LPS 
or saline (control). (A) Airway resistance, (B) tissue damping, (C) tissue elastance, and (D) hystersivity were 
measured to test the airway reactivity. Airway resistance (Raw; P=0.008) and tissue damping (G; P=0.037) were 
significantly decreased with 1% w/v MCh. Tissue elastance (H; P=0.151) and hystersivity (ɻ) showed no 
differences compared to the control group. LPS, lipopolysaccharide; MCh, methacholine. 
 
 
There were no differences in baseline measurements between the groups. Airway 
resistance (Raw; P=0.008; Figure 2A) and tissue damping (G; P=0.037; Figure 2B) did not 
increase at 1% w/v MCh in LPS-exposed lambs, whereas they increased in the saline 
control animals, indicating decreased airway reactivity with fetal LPS exposure. LPS-
exposed lambs and control lambs did not respond to lower MCh dosing. Tissue elastance 
(H; Figure 2C) and hysteresivity (ɻ; Figure 2D) were not different at any MCh concentration 
between LPS-exposed and control lambs. 
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Pulmonary inflammation  
Monocytes, lymphocytes and neutrophils were greatly increased in the BALF from the LPS-
exposed term fetal lambs relative to the controls 37 days after the last IA injection 
(P<0.001 versus control, Figure 3A). However, by 7 weeks there were no significant 
differences in the number of inflammatory cells in BALF for the LPS-exposed and control 
lambs (Figure 3B). 
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Figure 3: Leukocytes in BALF from lambs (A) at term and (B) at 7 weeks of age. Monocytes, lymphocytes and 
neutrophils were increased (P<0.001 versus control) in the LPS-exposed group at term. However, no significant 
differences were evident at 7 weeks, indicating resolution of the pulmonary inflammation present at term. BALF, 
bronchoalveolar lavage fluid; LPS, lipopolysaccharide. 
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Hydrogen peroxide responses of blood monocytes 
After stimulation in vitro with LPS, blood monocytes from control term lambs had no 
increased response, but after PamCysK4 stimulation a 6-fold increase was present (Figure 
4A). At 7 weeks, blood monocytes from control lambs responded to LPS and PamCysK4 
(16-fold and 14-fold increases respectively; Figure 4B). This change of monocyte responses 
between term and 7 weeks is explained by the maturation of the innate immune system in 
early postnatal life. LPS-exposed animals had a different monocyte response pattern. At 
term, a stimulation in vitro with LPS and PamCysK4 increased H2O2 5-fold and 9-fold, 
respectively (Figure 4A). This increase was still present at 7 weeks: 6-fold increase with LPS 
and 5-fold increase with PamCysK4 (Figure 4B). Comparing term LPS-exposed lambs and 
control lambs after a specific stimulation, an increased monocyte response was only 
present after stimulation with PamCysK4 (Figure 4A). At 7 weeks, no differences in the 
response were evident after PamCysK4 or LPS in vitro stimulation in LPS-exposed lambs 
when compared to control lambs (Figure 4B). 
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Figure 4: Hydrogen peroxide production by blood monocytes (A) at term and (B) at 7 weeks of age in cord 
blood. At term, hydrogen peroxide production was significantly increased after stimulation of cells with 
PamCysK4. At 7 weeks of age, this response was reversed, suggesting maturation of the immune system. LPS, 
lipopolysaccharide. (*) versus media; (+) versus control group; (o) LPS versus PamCysK4. 
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TGF-ɴ1 in lung tissue 
At term large amounts of bound TGF-ɴ1 were detectable with only a small concentration 
of free TGF-ɴ1, in lung tissue homogenate of the control group (Figure 5A). In LPS-exposed 
fetuses, bound TGF-ɴ1 in lung homogenate was decreased relative to controls at term 
(P<0.002). However, there was no increase in free TGF-ɴ1, which is the biological active 
component of TGF-ɴ1 that can impair lung development and cause inflammation and 
airway remodelling. At 7 weeks of age, free TGF-ɴ1 concentration was increased in the 
lung of LPS-exposed lambs (P=0.048, Figure 5B). 
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Figure 5:  TGF- ɴ1 was measured in homogenates of lung tissue from lambs (A) at term and (B) after 7 weeks of 
age. At term, the concentration of total and bound TGF-ɴ1 was significantly decreased after LPS exposure, but 
free TGF-ɴ1 was unchanged. At 7 weeks a significant increase of free TGF-ɴ1 was detected in the LPS group, but 
no differences in bound or total TGF-ɴ1 were found. LPS, lipopolysaccharide; n.s., not significant; TGF-ɴ1, 
transforming growth factor-beta 1. 
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Elastin 
At term, control and LPS-exposed lambs had a normal amount of elastin staining as 
concentrated elastin foci, with no differences between groups (Figure 6A) and no 
differences in the elastin deposition in the blood vessel walls (Figure 6B and 6C). At 7 
weeks, about 80% of the elastin was nonconcentrated in both animal groups, indicating 
lungs alveolarization and maturation (Figure 6D).There was less elastin deposition in the 
blood vessel walls of the LPS-exposed lungs at 7 weeks of age than in controls (Figure 6E 
and 6F). 
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Figure 6:  Elastin (stained in black) in lung tissue from lambs (A, C) at term and (B, D) at 7 weeks of age. (A, B, E) 
Elastin foci were distinguished between concentrated (black arrow) and non-concentrated (red arrow) foci. (C, D, 
F) Elastin scoring in the vessel wall was performed on a scale from 0-3. At 7 weeks less elastic fibers were present 
in the lungs after exposure to LPS. No differences in elastic foci were noticed at term and at 7 weeks of age. LPS, 
lipopolysaccharide. 
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Lymphocytes in the thymus and PMLN 
Lymphocyte populations in the thymus and PMLN had an increased percentage of CD4 
positive lymphocytes after LPS exposure at term (Figure 7A). CD8 positive and gamma-
delta positive lymphocytes were not different. In contrast, at 7 weeks (Figure 7B), 
percentages of CD4 positive were not different in the LPS-exposed lambs compared to the 
control group. However, in the thymus, there was a lower percentage of CD8 positive 
lymphocytes and in the PMLN CD8 positive lymphocytes were increased.  There was no 
effect of LPS exposure on gamma-delta positive lymphocytes in thymus and PMLN at 7 
weeks of age. Fetal LPS-induced inflammation was associated with an increase in 
CD4/CD25 double positive lymphocytes (Figure 7C) in both thymus and PMLN at term. 
After 7 weeks, no differences were measured in the thymus. However, the percentage of 
CD4/CD25 double positive was decreased in PMLN after LPS exposure. 
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Figure 7: Percentages of specific T lymphocytes in thymus and PMLN. (A) At term, the percentages of CD4 
lymphocytes were increased significantly in thymus and PMLN (34% and 46% respectively) of LPS-exposed lambs. 
After chorioamnionitis, CD8 lymphocytes and gamma-delta lymphocytes were not different. (B) The percentage 
of CD8 lymphocytes were decreased by 7 weeks (P=0.039) in the thymus of the LPS-exposed lambs. However, 
CD8 lymphocytes were increased (P<0.028) in PMLN. CD4 and gamma-delta lymphocytes showed no significant 
changes at 7 weeks. (C) CD4 co-expressing CD25 lymphocytes were increased in thymus and PMLN of 12% and 
16%, respectively, at term. In the thymus no significant changes were present after 7 weeks of age. However, in 
the PMLN a significant decrease of CD4 lymphocytes co-expressing CD25 was noticed in LPS exposed lambs at 7 
weeks (P<0.02). LPS, lipopolysaccharide; PMLN, posterior mediastinal lymph node. 
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Discussion 
 
In this study, we examined the effects of fetal chorioamnionitis induced by 3 IA injections 
of LPS from 90 to 110 days’ gestation on sheep at term and at 7 weeks of age. In previous 
experiments was reported profound changes in the pulmonary immune system after fetal 
exposure to LPS with an increase of immune cells and subsequent maturation of systemic 
monocytes into PU.1 expressing macrophages (24,25). In the current study, we also 
noticed significant increases in pulmonary immune cell populations, neutrophils in 
particular at term. This is remarkable as the fetal LPS exposure was 37 days before the 
increased neutrophils were detected. Neutrophils were not increased at 7 weeks of age. 
Monocytes and lymphocytes numbers that were elevated at term remained elevated at 7 
weeks of age in lambs exposed as fetuses to LPS. These changes in leukocyte populations 
may indicate an accelerated development of the pulmonary immune system after LPS-
induction. 
 
At the systemic level, IA LPS also induced an inflammatory response (18). Previously, our 
group showed that the functional response of blood monocytes from preterm LPS-
exposed lambs were similar to the blood monocytes of adult sheep (13,14). A functional 
assay in the current study demonstrated increased H2O2 production after PamCysK4 (a 
synthetic ligand for TLRs 1 and 2) stimulation of blood monocytes at term in fetal LPS-
exposed animals compared with controls. This result demonstrated that blood monocytes 
at term were competent to respond to TLR2, because of the fetal LPS exposure. At 7 
weeks, controls and LPS-exposed lambs were now similarly able to respond to PamCysK4 
stimulation. 
Changes in lymphocyte populations of the thymus and the PMLN of LPS-exposed 
preterm/fetal sheep were demonstrated in previous experiments (11). Furthermore, LPS-
induced chorioamnionitis resulted in a reduced size of the thymus (23). In the current 
study, the percentage of cytotoxic lymphocytes decreased in the thymus after fetal LPS 
exposure, but increased in the PMLN of LPS-exposed lambs. This could be explained by the 
migration of immune effector cells to the site of inflammation. In addition, the percentage 
of CD4+CD25+ T lymphocytes were significantly decreased in the PMLN suggesting less 
suppression of effector cells by regulatory T lymphocytes (Tregs). In the literature, it was 
proposed that a decrease in Tregs may play a role in the dysregulation of airway 
inflammation in asthma (6,26,27). Normally, Tregs can suppress established airway 
inflammation and airway hyperresponsiveness. Schaub et al. (28) demonstrated that cord 
blood from offspring of atopic mothers had fewer innate-induced Tregs, indicating a 
potential mechanism by which intrauterine immune modulation can occur and may 
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influence further atopic disease development. It also points to the intrauterine 
environment as a critical immune modulator. Interestingly, Szépfalusi et al. (29) 
demonstrated that allergens could be transferred across the placenta, supporting the 
theory that fetal T lymphocytes are exposed during gestation to maternally derived 
allergens and that the uterus may not be completely sterile. However, the effect of 
antenatal and postnatal exposure to allergens may have reinforcing effects because 
exposure to allergens early in life enhanced the development of airway 
hyperresponsiveness and impairment of lung function at school age (30). 
 
In our study, we tested the airway responsiveness to methacholine in lambs at 7 weeks of 
age. Airway resistance and tissue damping did not increase in LPS-exposed lambs at the 
highest MCh dosage (1.0% MCh) as it did in the controls. Interestingly, these results of 
decreased airway reactivity are in contrast with clinical observations of increased asthma 
after chorioamnionitis exposure (2). However, airway reactivity and immune dysfunction 
of the lungs do play a role in the development of asthma. The current study demonstrated 
structural changes in the vascular wall of the lungs. Less elastin was detected in blood 
vessels but more in lung parenchyma. This finding was surprising because elastin 
deposition is typically increased in blood vessels in ventilated animal models of lung injury 
(31). The low pulmonary blood flow in utero and spontaneous breathing after birth are not 
comparable to ventilated animal models to our model. Furthermore, decreased 
concentrations of bound and total TGF-ɴ1 were measured after chorioamnionitis at term. 
We speculate that the altered deposition of elastin in the vessel wall may be the result of 
the structural changes initiated before birth and that this is partially mediated by TGF-ɴ1. 
However these changes do not explain the decreased airway reactivity. In real life, 
children are exposed to many allergens, which are additional stimulators for airway 
reactivity and the later development of asthma. The allergen exposure was not controlled 
in these free living lambs to 7 weeks of age. Interestingly, Eder et al. (32) reported that 
exposure to LPS in early life protects against allergic sensitization, but not against asthma. 
This might be an explanation for the different outcome of airway reactivity in our study. 
Bischof et al. (33) demonstrated that age is important for asthma studies in sheep. 
Significant effects in the airway responsiveness were measured only after 5 months of 
age. Our studies at 7 weeks may have been in animals that were too young, altered 
responses to fetal exposure have not been tested previously. Another variable that may 
change the postnatal outcome is the gestational time of fetal exposure to 
proinflammatory stimuli. 
In conclusion, our results demonstrate that early fetal exposure to LPS caused residual 
lung inflammation, but the pulmonary inflammation had resolved by 7 weeks. However, 
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minor structural and functional changes, decreased airway reactivity, and changes in 
lymphocytes were noted at 7 weeks. The clinical relevance of these results is the 
demonstration that fetal exposure to chorioamnionitis can modulate postnatal immune 
status and responses. 
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Prenatal inflammation is known to be a major pathological component in preterm birth 
and impaired lung development (1,2). In addition, preterm birth seems to be related to 
the development of childhood wheezing (3,4). Nevertheless, the underlying mechanisms 
of these inflammatory processes and the associated pathology are not completely clear. 
The main focus of this thesis was to give insight into the postnatal persistence of fetal 
immune effects following a pro-inflammatory stimulus and how the duration of exposure 
to antenatal inflammation may affect the fetal lungs and airways as gestation advances till 
near-term and the first years after birth. 
 
Important role of inflammation during fetal development 
 
Up to 70% of preterm deliveries prior to 30 weeks gestation are affected by 
chorioamnionitis through direct contact with amniotic fluid or via the placental-fetal 
circulation (5). Chorioamnionitis affects neonatal outcomes in an organ-dependent way 
(6), but is primarily attributed with alterations in lung development and may negatively 
affect neonatal outcomes by modulating the fetal immune system (7,8). However, results 
of these immune responses are limited to short term exposure to pro-inflammatory 
agonists. No experimental studies have examined the persistence of fetal immune 
modulations following a pro-inflammatory stimulus and how this may affect the fetal 
response as gestation advances till near-term. 
Therefore, in chapter 2, we hypothesized that lipopolysaccharide (LPS)-induced 
chorioamnionitis would cause persistent fetal pulmonary responses as the lungs develop 
further in utero. To characterize the effects of LPS on the fetal lung, we assessed lung 
homeostasis after single or repetitive doses of LPS. Consistent with our hypothesis, intra-
amniotic LPS exposure resulted in changes in the fetal lung inflammatory responses in the 
course of gestation with involvement of an alveolar macrophage response shown by an 
increased PU.1 expression (a hematopoietic transcription factor). In addition, delayed 
increases in Toll-like receptor (TLR)2 and TLR6 mRNA levels 15 days after the initial 
exposure to the TLR4 agonist LPS might have clinical implications for the chronic and often 
polymicrobial organisms associated with chorioamnionitis (9). However, our finding of 
reduced mast cell populations soon after LPS exposure is in contrast with our hypothesis 
that LPS exposure would increase mast cells. Mast cells in the lower airways normally 
contribute to the development of asthma and allergic diseases (10). In addition, there is a 
possible relation between chorioamnionitis, preterm birth, and the development of 
asthma later in life (3,4). Therefore, further investigation of mast cell populations and 
function are needed to provide insights into the mechanisms and development of asthma 
and allergic diseases after preterm birth. 
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Besides immunologic changes, structural changes measured by elastin foci, resulted in 
more diffusely localized elastin foci in the more immature fetal lambs, a more normal 
distribution with localization of elastin foci at the tips of alveolar septa was re-established 
near-term, indicating recovery with advancing gestation. The mechanism by which the 
fetal lung repairs the abnormal elastin response is unknown. Importantly, overall 
differences in the results were demonstrated after a single or repetitive dose of LPS, which 
suggests that the pulmonary immune response may be dependent on the intensity and/or 
persistence of the LPS exposure. With chorioamnionitis in human pregnancies, fetuses will 
be continuously exposed to bacteria until delivery, which will challenge the immune 
system permanently. Therefore, it is important to mimic this continuous exposure of LPS 
during further research. 
In chapter 3 we were interested in the gender differences during prenatal lung 
development. In the perinatology, gender differences for short- and long-term outcomes 
of the infants are often reported (11-15). It was suggested that slower lung maturation 
among male fetuses is a major contributing factor to gender differences in neonatal 
mortality (15). In addition, an increased vulnerability of perinatal mortality among male 
neonates might also be the result of gender differences in the development and function 
of the immune system (16). In our study, we did not detect any potentially underlying 
differences in pulmonary and systemic markers of inflammation after antenatal exposure 
to LPS. However, we observed larger improvements in lung compliance after LPS-induced 
intrauterine inflammation among female preterm fetuses compared with males. A 
decrease in lung compliance was detectable 2 days after intrauterine LPS exposure only in 
male fetuses. Conversely, lung compliance was enhanced 7 days after LPS, when lung 
compliance was again better in female than in male fetuses. We propose that these 
differences may explain at least part of the female advantage in survival as well as in 
outcome among survivors after chorioamnionitis and preterm birth. To examine the 
mechanism behind this female advantage we analyzed the mean alveolar size and alveolar 
wall thickness without any differences noticed. This suggests that the female advantage in 
lung gas volume is not based on lung histology, but might contribute to the theory that 
the surfactant deficiency in male lungs might play a key role in the female advantage after 
preterm birth (17-20). Further investigations are required to test this proposed 
mechanism between sexes. 
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Effect of LPS-induced inflammation on lung development after birth 
 
Exposure to antenatal inflammation is a double-edged sword to the fetal lung: on the one 
hand, it enhances lung maturation; on the other hand, it stops the further development of 
the alveoli resulting in a reduced surface area for gas exchange (1,2,21). These very same 
infants will need supplemental oxygen, which is the clinical definition of 
bronchopulmonary dysplasia (BPD) (22-24).  Long-term studies showed persisting lung 
function abnormalities in children with BPD resulting in airway obstruction, airway 
hyperreactivity and hyperinflation (25,26). Chorioamnionitis is correlated with a 4.4-fold 
increased risk for developing physician-diagnosed asthma in preterm babies after 
correction for confounding factors (3). This last observation is in contrast to the hygiene 
hypothesis, in which infections during early childhood are associated with a decreased risk 
of subsequent asthma and allergic diseases (27-29). The relationship between antenatal 
inflammatory exposures and postnatal abnormalities seems to be confounded by the fetal 
response to inflammation. Hardly anything is known about how this fetal response to 
inflammation may affect the lung development during the first years after birth. 
In chapter 4, we firstly were interested in the differences of airway smooth muscle 
reactivity in sheep at different ages without antenatal inflammation. A model of ovine 
precision-cut lung slices (PCLS) was established for the measurement of airway responses 
to early allergic response mediators and to allergens (after passive sensitization) in 
newborn and adult animals. Many of the responses were similar in newborn and adult 
sheep, such as the bronchoconstriction to electric field stimulation (EFS), to allergen (after 
passive sensitization) and to the mediators methacholine, histamine and endothelin-1. 
However, the response to leukotriene D4 (LTD4), the thromboxane analogue U46619 and 
serotonin depended on the age of the sheep. The response to serotonin and U46619 was 
weaker in newborn sheep than in adult sheep, whereas the response to LTD4 was stronger 
in newborn sheep. The notable differences between newborn and adult sheep 
demonstrate the importance of age in such studies, since leukotrienes contribute to 
airway obstruction in many human asthmatics (30).  
Therefore, in chapter 5 we focused on the effects of intra-amniotic LPS-induced 
chorioamnionitis at 7 weeks old sheep, which is comparable to 4-5 years of age in humans. 
We hypothesized that fetal innate immune responses to antenatal inflammation would 
alter postnatal systemic immune and airway responsiveness. Our results demonstrated 
that early fetal exposure to LPS caused residual lung inflammation, but the pulmonary 
inflammation had resolved by 7 weeks. However, minor structural and functional changes, 
decreased airway reactivity and changes in lymphocytes demonstrate persistent effects of 
fetal exposure to LPS at 7 weeks postnatal. Interestingly, the results of decreased airway 
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reactivity are in contrast with clinical observations of increased asthma after 
chorioamnionitis exposure (3). However, airway reactivity and immune dysfunction of the 
lungs do play a role in the development of asthma. Bischof et al. demonstrated that 
significant effects in the airway responsiveness were measured after 5 months of age (31). 
This suggests that examination of the airway reactivity at 7 weeks may have been in 
animals that were too young. The clinical relevance of our results is the demonstration 
that fetal exposure to antenatal inflammation can modulate postnatal immune status and 
responses. 
 
Implications and future perspectives 
 
To come up with new preventive and therapeutic strategies for asthma, it is highly 
important to understand the mechanisms that drive normal lung development and how 
they are driven off course by the events that surround preterm birth (Figure 1). 
 
Figure 1: Overview of the most common antenatal and postnatal events to which preterm infants are exposed. 
Both antenatal and postnatal exposures can influence the neonatal immune response and subsequent neonatal 
outcome (6). 
 
In recent years, the fetal immune response toward the perinatal events has been 
identified as a key determinant for neonatal outcomes (32,33). An accurate and timely 
immune response towards pathogens is essential to protect against tissue damage and 
disease (34). After controlling the infection it is essential that resolution of the 
inflammation is initiated by control mechanisms to prevent further tissue damage and to 
enable wound healing (35,36). However, it seems that the preterm infants have a limited 
ability to resolve the pro-inflammatory processes, especially when exposed to antenatal 
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events such as chorioamnionitis. It has been demonstrated that monocytes from preterm 
sheep function differently in respect to initiation and resolution of inflammation 
compared to adult cells and that their function can be further modulated by various 
stimuli such as endotoxin (lipopolysaccharide [LPS]), glucocorticoids and surfactant, which 
are all common exposures for a preterm infant (37-39) (Figure 1). This sustained 
inflammation in the neonate seems to be closely associated with an increased risk for 
adverse outcomes such as pulmonary complications, but also brain damage and intestinal 
complications (6,40). The follow-up studies of former preterm showed clearly that their 
lung function and airway reactivity remains impaired (41,42). 
Asthma is a chronic lung disease characterized by episodes of airflow obstruction. The 
prevalence and incidence of asthma is increasing worldwide in the last few decades 
(43,44), especially among children and adolescents (45,46). Asthma has become the most 
common chronic disease among children in many countries and is one of the major causes 
of hospitalization among those younger than 15 years of age (47). It is the leading cause of 
missed school days due to the chronic condition. Differences in major activity limitations 
for children with and without asthma are substantial. Children with asthma are almost five 
times more likely to have activity limitations than children without asthma. In addition, to 
the considerable distress for the children and inconvenience for the families, childhood 
asthma is a major source of medical expense for society. Medical treatment with anti-
inflammatory agents (especially inhaled steroids) and bronchodilators is necessary to 
prevent and control asthmatic attacks. The total annual health care expenditure on a 
single asthmatic child is 2.8 times higher than the costs of a non-asthmatic child (47). 
Although, many treatments already exist that suppress the symptoms of the disease, 
these treatments do not cope with the cause of the disease. Clearly, childhood asthma has 
become a major public health problem that needs considerable effort to reverse the 
increasing trend in its incidence. Fetal life exposures are thought to contribute to these 
increases (3,48,49). Although asthma is probably a heterogeneous disease or syndrome, 
four factors and/or events consistently emerge for their ability to significantly influence 
asthma development in the first decade of life: 1) prematurity, which is associated with 
changes in pulmonary function, including those that have found effects extending into 
adolescence; 2) immune response aberrations, which appear to be defined best by the 
concept of cytokine dysregulation; 3) gene-environment interactions that need to occur at 
a critical time-period in the development of the immune system or the lung; and 4) lower 
respiratory tract infections, in particular respiratory syncytial virus (RSV). However, it 
remains to be established how any one or all of these factors, either independently or 
interactively, influence the development of childhood asthma. Therefore, children with 
asthma after prematurity need long-term follow-up studies. 
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Previous animal studies have provided some insight into the long-term consequences after 
preterm birth. It may well be modulated to a significant degree by perinatal factors. 
However, many new questions have arisen, requiring new animal studies, clinical studies 
and alternative approaches to become answered. Future studies should evaluate the 
effects of cytokine dysregulation such as T helper 1/T helper 2 (Th1/Th2) imbalance. 
Balanced Th1/Th2 immunity is a physiologic state among healthy individuals, and 
excessive responses to either Th1 or Th2 direction are harmful (50). Th1-type immune 
responses are involved in delayed type immune responses against microbe, whereas Th2-
type immune responses are associated with immunoglobulin E (IgE) production and 
allergic inflammation. The postnatal downregulation of the Th2 immunity is a complex 
process with involvement of various cells and mediators (44,51). Among many cytokines 
and chemokines, Th1 cell secreted interferon-gamma (IFN-ɶ) has been suggested to have 
an important role in downregulating the postnatal Th2 immunity. In addition, 
chorioamnionitis is associated with a strong pro-inflammatory response with increased 
levels of TNF-ɲ, IL-6, and IL-8 (52,53). These inflammatory cytokines may be a response to 
infection and also a trigger for premature delivery. Specifically, human decidual cells 
increase the production of delivery promoting factors such as prostaglandin (PG)E2 and 
PGF2 in response to inflammatory cytokines including IL-1a, IL-1b, and TNF-ɲ (54). COX-2 
plays a predominant role in PG formation during inflammation and LPS is well described as 
a potent stimulus to COX-2 induction (55, 56). Some of the cytokines which are a response 
to infection may be involved in chronic respiratory disease development. For example, 
TNF-ɲ variants have been found to be associated with recurrent wheezing after RSV 
bronchiolitis (57) and IL-8 levels were increased in children who developed wheezing 
illnesses in response to rhinovirus with an additional risk of persistent wheezing till follow 
up at age 3 years (58,59). Thus, the same cytokines which are generated as part of the 
inflammatory response to chorioamnionitis may play a role in asthma and responses to 
respiratory viral illness (60). However, only a fraction of children develop recurrent 
wheezing following RSV infections, despite the fact that nearly all children have been 
infected at least once by 2 years of age. Thus, although RSV infections may have the 
potential of targeting the inflammatory response to the lower airway, they may only be 
able to do so during a vulnerable time-period of immune system or lung development. 
This developmental component may further reflect important gene–environment 
interactions that regulate both short- and long-term airway physiological alterations that 
manifest themselves clinically as childhood asthma. The obtained knowledge from these 
future studies can be used to test the clinical association of chorioamnionitis and asthma 
with the ultimate aim of prevention. 
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Conclusion 
 
In summary, our findings provide new insights into how the lung development is 
influenced by antenatal inflammation as gestation advances and during the first period 
after birth. Although our studies were performed in fetal and newborn lambs in which the 
developing lung is highly similar to that in humans, they were also limited by this 
observational approach. To confirm the association between chorioamnionitis-induced 
preterm birth and asthmatic symptoms, a more optimized animal model needs to be 
developed. Nonetheless this thesis has identified a potential link between activation of the 
prenatal immune status and impaired lung development, resulting in altered airway 
reactivity postnatal, and should provide a basis for future research towards the 
understanding and treating of asthma in early childhood after preterm birth. 
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Vroeggeboorte na antenatale inflammatie als onderliggende oorzaak van 
bronchiale hyperreactiviteit 
 
Vroeggeboorte 
 
Over vroeggeboorte, ook wel prematuriteit genoemd, wordt gesproken bij een 
zwangerschapsduur van minder dan 37 weken (normale duur is 37-42 weken). Het komt 
voor bij 5-13% van alle zwangerschappen in de Westerse wereld. In 2008 werden in 
Nederland 7,7% van alle kinderen te vroeg geboren. Vroeggeboorte is de belangrijkste 
oorzaak van ziekte en sterfte bij zuigelingen. Hoe korter de zwangerschapsduur, hoe 
groter de kans is op ziekte en sterfte. Dus elke week dat een zwangerschap langer duurt, 
stijgt de kans op overleven. Hoewel maar 7,7% van alle kinderen geboren wordt voor de 
37ste zwangerschapsweek, maken zij 75% uit van alle zuigelingensterfte in Nederland in 
2008. Vroeggeboorte is niet alleen risicovol rondom de bevalling maar kan ook één jaar na 
de bevalling nog ongunstige effecten hebben voor het kind en mogelijk zelfs nog later in 
de ontwikkeling. 
 
Vroeggeboorte kan verschillende oorzaken hebben en wordt grofweg ingedeeld in twee 
hoofdcategorieën. De eerste categorie is de vroegtijdige zwangerschaps-beëindiging op 
basis van medische indicatie of gezondheidsrisico voor moeder of kind. Bij deze 
geïndiceerde vroeggeboorte wordt ingegrepen door middel van een keizersnede. Bij de 
tweede categorie, de spontane vroeggeboorte, is de meest waarschijnlijke oorzaak een 
bacteriële infectie van de vruchtvliezen (chorion en amnion) en het vruchtwater 
(amnionvocht). Deze bacteriële infectie wordt chorioamnionitis genoemd en is de oorzaak 
van 70% van alle vroeggeboorten. Het is dus de meest voorkomende oorzaak. Meestal 
vertoont de moeder geen klinische symptomen van deze infectie en kan dit pas na de 
bevalling vastgesteld worden door de placenta (dit is de moederkoek) in een laboratorium 
te laten onderzoeken. Het is niet duidelijk hoe deze bacteriële infecties ontstaan tijdens 
de zwangerschap, maar waarschijnlijk banen de bacteriën zich een weg vanuit de vagina 
naar de baarmoeder en de vruchtvliezen om uiteindelijk in het vruchtwater terecht te 
komen. Doordat de ongeboren baby het vruchtwater inslikt en inademt zal de baby 
geïnfecteerd raken. Er zijn verschillende soorten bacteriën bekend die in de vruchtvliezen 
en het vruchtwater voorkomen van zuigelingen met chorioamnionitis. Het immuun 
systeem van de zuigelingen reageert op een stof in het buitenmembraan van deze 
bacteriën. Deze stof is lipopolysaccharide (afgekort: LPS) en wordt in het wetenschappelijk 
onderzoek vaak gebruikt om een infectie na te bootsen. 
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In de kindergeneeskunde wordt daarnaast vaak gezien dat het verschil in geslacht van 
invloed is op de zuigelingensterfte bij vroeggeboorte. De zuigelingensterfte is bij te vroeg 
geboren jongetjes hogere dan bij meisjes. Er wordt gedacht dat de langzamere longrijping 
onder ongeboren jongetjes een belangrijke factor is die bijdraagt tot een verschil in 
zuigelingensterfte tussen jongens en meisjes, maar ook een verschil in de ontwikkeling van 
het immuun systeem kan hieraan bijdragen. 
 
Bronchiale hyperreactiviteit en astma ontwikkeling 
 
Blootstelling aan chorioamnionitis heeft twee kanten: enerzijds zorgt het voor een 
versnelde longrijping, anderzijds stopt het de verdere ontwikkeling van de longblaasjes. 
Het gevolg is dat er minder en erg grote longblaasjes ontstaan. De longen zijn nog 
onderontwikkeld met een te kleine longoppervlakte waardoor te vroeg geboren baby’s 
(prematuren) niet genoeg zuurstof binnen krijgen en met extra zuurstof beademd moeten 
worden. Deze behandeling is noodzakelijk voor de overleving van de prematuren maar 
gaat ook gepaard met schade aan de onderontwikkelde longen. Hierdoor ontwikkelen 
deze kinderen chronische longschade (bronchopulmonale dysplasie; afgekort als BPD). 
Langdurige beperking van de longfunctie bij kinderen met BPD leidt uiteindelijk tot 
luchtwegvernauwing en overmatige reactie van de luchtwegen op prikkels, dit wordt 
‘bronchiale hyperreactiviteit’ genoemd. Het is bij prematuren bekend dat chorioamnionitis 
gerelateerd is aan een vier keer hoger risico op het ontwikkelen van astma op latere 
leeftijd.  
Als men echter kijkt naar infecties die ontstaan in de vroege kinderjaren, dus na de 
geboorte, dan blijkt dat astma minder voorkomt bij boerenkinderen (meer contact met 
bacteriën en schimmels) en antroposofische kinderen (meer kinderziektes, want ze zijn 
niet gevaccineerd uit levensbeschouwingsmotief). Bij deze kinderen is er sprake van een 
hogere infectiegraad op jonge leeftijd en dit lijkt een beschermende factor te zijn voor het 
ontwikkelen van astma. Hieruit blijkt dus het belang van de periode van blootstelling aan 
een infectie of deze tijdens de zwangerschap of na de geboorte plaatsvindt. 
Teruggaand naar de relatie tussen een bacteriële infectie tijdens de zwangerschap en een 
veranderde longontwikkeling op latere leeftijd, lijkt dit veroorzaakt te worden door een 
verstoorde reactie van de ongeboren baby op deze infectie. Het is echter nauwelijks 
bekend hoe deze infectie de longontwikkeling ongunstig beïnvloedt tijdens de 
zwangerschap en de eerste jaren na de geboorte. Kennis van deze processen is dan ook 
noodzakelijk voor een beter inzicht in de ontwikkeling van astma na vroeggeboorte en de 
ontwikkeling van preventie- en behandelopties voor astma. 
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Dit proefschrift 
 
In dit proefschrift is onderzocht hoe de normale longontwikkeling en longfunctie 
beïnvloed wordt door een ontsteking van de vruchtvliezen en het vruchtwater gedurende 
de zwangerschap tot aan de kindertijd. Het zijn namelijk vooral de lange termijn effecten 
die nauwelijks onderzocht zijn. Voor dit onderzoek is gebruik gemaakt van een 
schaapmodel, omdat de laatste stadia van schaapfoetussen sterke gelijkenis hebben met 
de mens. Verder geldt voor schapen dat een leeftijd van 7 weken ongeveer overeenkomt 
met een leeftijd van 4-5 jaar bij de mensen. 
In hoofdstuk 2 wordt beschreven hoe de longontwikkeling en het immuunsysteem van 
schaapfoetussen reageert op de blootstelling aan een ontsteking in het verloop van de 
zwangerschap. Hiervoor werden de longen onderzocht op 3 verschillende momenten in de 
zwangerschap. Uit dit onderzoek blijkt dat de immuunrespons in de longen afhankelijk is 
van de intensiteit en continuïteit van de blootstelling aan LPS. In menselijke 
zwangerschappen wordt de ongeboren baby voortdurend blootgesteld aan bacteriën tot 
aan de bevalling en zal het immuunsysteem dus voortdurend geprikkeld worden. Het is 
dan ook belangrijk om deze continue blootstelling van LPS na te bootsen in toekomstig 
onderzoek. In hoofdstuk 3 is onderzocht of de longontwikkeling verschilt tussen de nog 
ongeboren jongens en meisjes na blootstelling aan een ontsteking in het vruchtwater. Uit 
dit onderzoek blijkt dat het longvolume, en daarmee ook de longrijping, groter is bij 
meisjes dan bij jongens na blootstelling aan chorioamnionitis. Deze versnelde longrijping 
bij ongeboren meisjes is een voordeel in de overleving na vroeggeboorte. Het mechanisme 
achter dit voordeel lijkt niet gebaseerd te zijn op de longstructuur volgens dit onderzoek, 
maar kan wel bijdragen tot de theorie dat ‘surfactant’-tekort een belangrijke rol speelt. 
Surfactant is een stof dat zorgt voor een verlaagde oppervlakte spanning, vergelijkbaar 
met zeep in water. Eerdere studies hebben aangetoond dat deze stof in de longen bij 
ongeboren meisjes vroeger in de zwangerschap stijgt dan bij de ongeboren jongens, 
mogelijk speelt dit een rol in het verschil van longrijping tussen de beide geslachten. Deze 
theorie zal in de toekomst verder onderzocht gaan worden. 
Om het effect van chorioamnionitis op een astmatische aandoening na de geboorte 
verder te kunnen onderzoeken in schapen, is een onderzoeksmodel ontwikkeld waarbij de 
samentrekkingen van de luchtwegen gevisualiseerd en onderzocht kan worden. In 
hoofdstuk 4 is dit onderzoeksmodel verder uitgewerkt bij schaapfoetussen die niet zijn 
blootgesteld aan een ontsteking in de baarmoeder. Bij deze schaapfoetussen werden na 
de geboorte de luchtwegen blootgesteld aan allergische prikkelingen, om zo de normale 
reactiviteit van de luchtwegen te kunnen onderzoeken. Hierbij werd aangetoond dat er 
een duidelijk verschil is in samentrekkingen van de luchtwegen tussen pasgeboren 
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schapen en 18 maanden oude schapen. Het is belangrijk dat dit verschil is aangetoond 
omdat dit het belang van leeftijd weergeeft voor het verschil in resultaten bij dergelijke 
studies. In hoofdstuk 5 is verder gekeken naar de effecten van blootstelling aan LPS bij 7 
weken oude schapen. De resultaten toonden aan dat de vroege blootstelling aan LPS zorgt 
voor activatie van het immuun systeem in de longen, maar dat deze activatie met 7 weken 
bijna helemaal is verdwenen. Bij 7 weken worden wel kleine structurele en functionele 
veranderingen gezien, verminderde reactiviteit van de luchtwegen waargenomen en 
aanwezigheid van bepaalde immuun cellen (lymfocyten) aangetoond. Interessant is dat de 
resultaten van verminderde luchtweg reactiviteit in tegenstelling is tot de klinische 
waarnemingen van een toename van astma na blootstelling aan chorioamnionitis. Dit 
komt mogelijk doordat het onderzoek van de luchtwegreactiviteit bij 7 weken nog te 
vroeg is, stijging in luchtwegreactiviteit treedt waarschijnlijk op latere leeftijd pas op. Dit 
zal in de toekomst verder onderzocht gaan worden. De klinische relevantie van de 
resultaten in dit hoofdstuk is het bewijs dat blootstelling van de ongeboren baby aan een 
ontsteking in het vruchtwater van invloed is op veranderingen in het immuun systeem 
vlak na de geboorte en op latere leeftijd structurele en functionele veranderingen laat 
zien. 
 
Conclusie 
 
Een bacteriële infectie van de vruchtvliezen en het vruchtwater staat bekend als een 
belangrijke oorzaak voor vroeggeboorte en een gestoorde longontwikkeling van de 
zuigeling. Daarnaast lijkt vroeggeboorte gerelateerd te zijn aan de ontwikkeling van een 
piepende ademhaling tijdens de kindertijd. Er is een dringende behoefte aan kennis naar 
de onderliggende mechanismen van deze ontstekingsprocessen en de gestoorde 
longontwikkeling op latere leeftijd. Het onderzoek dat gepresenteerd wordt in dit 
proefschrift heeft hieraan een bijdrage geleverd door aan te tonen dat blootstelling aan 
een ontsteking in het vruchtwater resulteert in een mogelijk verband tussen activatie van 
het immuun systeem en een gestoorde longontwikkeling tijdens de zwangerschap, met als 
gevolg een veranderde luchtwegreactiviteit na de geboorte. Deze resultaten bieden 
nieuwe inzichten in hoe de ontwikkeling van de longen wordt beïnvloed door een infectie 
tijdens de zwangerschap en de eerste jaren na de geboorte. Het onderzoek in dit 
proefschrift geeft een basis voor toekomstig onderzoek naar meer inzicht en de 
behandeling van astma in de vroege jeugd van te vroeg geboren kinderen. 
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The main focus of this dissertation was to give insight into the postnatal persistence of 
fetal immune effects following a pro-inflammatory stimulus and how the duration of 
exposure to antenatal inflammation may affect the fetal lungs and airways as gestation 
advances till near-term and the first years after birth. 
 
Relevance and target groups 
Chorioamnionitis affects neonatal outcomes in an organ-dependent way, but is primarily 
attributed with alterations in lung development and may negatively affect neonatal 
outcomes by modulating the fetal immune system. However, results of these immune 
responses are limited to short term exposure to pro-inflammatory agonists. In the last 
years translational research with various animal models has been helpful to answer some 
basic questions about the effect of various fetal exposures on different organs. However, 
the various animal models differ in their developmental biology compared to humans. 
Development of the ovine lung is highly similar to that of humans. Sheep undergo the 
alveolar phase of lung development in utero and these animals are large enough to 
manipulate them and to induce an intrauterine inflammation for example by 
lipopolysaccharide (LPS). Sheep have, in contrast to mice, a bronchial circulation, bronchial 
glands and mast cells that respond to stimuli similarly to the human lung with both early 
and late phase responses. In addition, sheep can be sensitized to house dust mite antigen 
which is a common human antigen in asthma. Recently, airway remodelling (increased 
airway collagen and smooth muscle with hyperplasia of goblet cells) following repeated 
airway exposures of sheep to house dust mite (HDM) was reported. Sheep respond to 
HDM sensitization and airway challenges with a complete allergic/asthma response similar 
to that which occurs in humans. Therefore, preterm sheep are considered as an excellent 
translational model to study the effects of antenatal events on the developing fetus till 
adolescence in relation to the development of asthma. 
Asthma is the most common chronic disease affecting children, resulting in constriction of 
the airway muscles and swelling of bronchioles; breathing passages are narrowed and 
breathing becomes very difficult. The outcome is a wheezing phenotype or childhood 
asthma which limits children's daily activities and affects their social activities. Specific risk 
factors during pregnancy can influence the risk of wheezing in early childhood. Maternal 
smoking, low maternal age, early bottle feeding, low birth weight and prematurity are 
associated with lower respiratory tract illness in the first 2 years of life. Prematurity and 
low birth weights are considered significant risk factors for reduced lung function at school 
age and the development of childhood asthma. The link with preterm birth is of significant 
public health relevance because of the increasing incidence of both entities. Wheezing is 
common in young infants and toddlers with 27% of all children having at least one 
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wheezing episode by the age of 9 years. For some of these children these asthmatic 
symptoms seem to remit with time, but many children develop asthmatic symptoms 
which persist throughout their life and are associated with more severe symptoms ending 
in the loss of lung function. About 15% of the wheezing infants develop persistent 
wheezing and clinical asthma later in life. Therefore, surviving preterm children are the 
target population for the clinical application of the identified mechanisms. 
 
Activities, innovations and implementations 
In summary, our findings have identified a potential link between activation of the 
prenatal immune status and impaired lung development, resulting in altered airway 
reactivity postnatal, and should provide a basis for future research towards the 
understanding and treating of early childhood asthma after preterm birth. The obtained 
knowledge from these future studies can be used to test the clinical association of 
chorioamnionitis and asthma with the ultimate aim of prevention. In addition, our findings 
demonstrated that infections may have the potential of targeting the inflammatory 
response to the lower airway, but may only be able to do so during a vulnerable time-
period during development of the immune system or lung. This developmental 
component may further reflect important gene-environment interactions that regulate 
both short- and long-term airway physiological alterations that manifest themselves 
clinically as childhood asthma. Good and large clinical and biological databases during 
pregnancy and after preterm birth are needed to substantiate this association in patients. 
Gender differences were observed in this dissertation. For example, female preterm 
fetuses had larger improvements in lung compliance after an intrauterine inflammation 
compared with males, which may explain at least part of the female advantage in survival 
after chorioamnionitis and preterm birth. Our findings suggest that the female advantage 
in lung gas volume is not based on lung histology, but might contribute to the theory that 
the surfactant deficiency in male lungs might play a key role in the female advantage after 
preterm birth. These results demonstrate the importance to differentiate between sexes 
in future experiments and outcomes. Databases and prediction models will benefit from 
this finding in the analysis and concept of new studies where the gender and lung 
development must be taken into account. 
Furthermore, the knowledge of airway smooth muscle reactivity obtained with sheep 
precision-cut lung slices (PCLS) in this dissertation have been demonstrated to be useful 
for the measurement of airway responses to different early allergic response mediators 
and to allergens in this dissertation. It provided new inside in mechanisms of cholinergic 
airway contraction. Medication affecting airway constriction can be tested in this model to 
pave the way for clinical studies. This is a new step towards the understanding and 
| Valorization 
 
 
| 104 
 
treating of early childhood wheezing after preterm birth which has to be tested in clinical 
trials in ongoing research collaboration between pharmacology and pediatrics. 
 
 
 
 
 
105 | 
 
 
 
 
Dankwoord / Acknowledgements 
 
 
 
 
 
 
 
 
 
 
| Dankwoord 
 
 
| 106 
 
Het is gelukt, mijn proefschrift is klaar! 2014 is een jaar waarin ik niet alleen mijn 
promotietraject afrond maar waarin ik ook mijn geneeskundeopleiding afrond. Voor mij 
dus een bijzonder jaar! Uiteraard zou dit nooit gelukt zijn zonder een fantastische groep 
van collega’s, vrienden en familie om me heen. Graag wil ik op deze wijze een woord van 
dank richten aan iedereen die op enigerlei wijze heeft bijgedragen aan de totstandkoming 
van dit proefschrift. 
 
Mijn eerste dank gaat uit naar mijn promotoren, prof. dr. Boris Kramer en prof. dr. Luc 
Zimmermann, en copromotor Privatdozent dr. Christian Martin. Jullie hebben mij de 
gelegenheid gegeven om dit promotietraject te doorlopen, bedankt voor deze 
waardevolle ervaring. 
Boris, voor jou een speciale dank! Het was een groot avontuur om dit promotietraject te 
combineren met mijn geneeskundeopleiding, niet iedereen was ervan overtuigd dat dit 
zou gaan lukken. Jij hebt altijd vertrouwen in me gehad en dat heb ik al die jaren enorm 
gewaardeerd. Je bent een fantastische mentor en jouw inspirerende en positief kritische 
begeleiding heeft mij gebracht tot waar ik nu ben. Dank daarvoor! 
 
Ik dank de leden van de beoordelingscommissie, prof. dr. Edward Dompeling, prof. dr. 
Sidarto Bambang Oetomo, prof. dr. Irwin Reiss, prof. dr. Emiel Wouters, prof. dr. Servaas 
Morré voor hun bereidheid om dit proefschrift op wetenschappelijke inhoud te 
beoordelen. 
 
Om de voorbije jaren door te komen, helpt de steun van een groep geweldige collega’s die 
klaarstaan om bij te springen in tijden van nood en om even te ontspannen tijdens een 
kopje koffie/thee/water. Dank aan Nico Kloosterboer en Lilian Kessels die mij vele malen 
hebben geholpen in het lab. Hoofd van het lab Tim Wolfs, voor jou een woord van dank. 
Jouw komst heeft een frisse en kritisch blik over de afdeling gebracht, dit heeft mij 
gestimuleerd om verder te groeien en evolueren als onderzoeker. Verder wil ik graag 
Eduardo Villamor, Danilo Gavilanes en Freek van Iwaarden bedanken voor hun 
wetenschappelijk input tijdens de research meetings over de jaren. Ook dank aan de 
andere medewerkers, promovendi en oud-promovendi bij de afdeling 
Kindergeneeskunde, Bea Zoer, Coen Willems, Jennifer Collins, Elke Kuypers, Reint 
Jellema, Daan Ophelders, Monique Willems, Maria Nikiforou, Sizzle Vanterpool, Leon 
Janssen, Saskia van der Sterren, Rob Moonen, Jasper Been, Kim van de Kant, Ester 
Klaassen, en Sasha Hutchinson voor de gezellige tijd tijdens mijn onderzoekstijd bij 
Kindergeneeskunde. Tamara Cauberg-Smits, Peggy van den Heuvel en Natascha 
Vrijhoeven-Pieters, bedankt voor de onmisbare secretariële ondersteuning. 
Acknowledgements | 
 
 
107 | 
 
Tijdens mijn PhD periode heb ik niet alleen veel tijd doorgebracht in het lab, maar ook veel 
uren in het CPV (Centrale Proefdier Voorzieningen). Graag wil ik dan ook de medewerkers 
van het CPV, Saskia Seeldrayers, Barry Plooyer, Joyce Suyk, Sanne Bout, Petra Dijkstra, 
Frans Slangen en Noortje Peeters bedanken voor hun hulp en toewijdingen bij het 
opzetten en uitvoeren van de schaapexperimenten. Daarnaast dank aan de studenten Luc 
Ploum, Sophie Kienhorst, Pim Boden, Manuel Noben, Anne-Sophie Warda en collega’s 
Marjolein Caron en Yixuan Zhang voor jullie hulp bij nachtdiensten van de bevallingen van 
de schapen. Marco Schlepütz vielen Dank für deine Hilfe bei der Verarbeitung des 
Schafenmaterials und für die lustige Gespräche. Das Wort ‘Kliko’ und den Satz ‘kapot 
gemaakt’ werde ich immer mit einem Lächeln erinnern. Außerdem Dank an deine Kollegen 
Stefan Uhlig, Constanze Dassow und Peter König an den Universitäten von Aachen und 
Lübeck für die angenehme Zusammenarbeit. Darüber hinaus möchte ich Steffen 
Kunzmann an die Universität von Würzburg danken für die nette Zusammenarbeit. 
Zoals uit bovenstaand al naar voren komt werkt een goede wetenschapper niet geïsoleerd 
op het lab maar streeft naar het functioneren in een internationaal netwerk en het 
overleggen met collega’s van alle windstreken met verschillende expertises. Behalve de 
samenwerking met collega’s in Duitsland, heb ik ook de kans gehad om samen te werken 
met onze collega’s in Perth, Australië. 
I would like to thank the research-team in Perth at the University of Western Australia for 
performing the annual sheep experiments and their additional scientific input: Jane 
Pillow, John Newnham, Graeme Polglase, Ilias Nitsos, Suhas Kallapur, Matthew Kemp, 
Manfred Beilharz, and Andrea Lee. Furthermore, I would like to address a special ‘thank 
you’ to Alan Jobe for his invaluable scientific remarks and suggestions during my PhD-
project. You have taught me a great deal about writing scientific papers, I always looked 
forward to receive new useful feedback and comments on my manuscript from you. Thank 
you for that, you are a true inspiration! 
 
Voordat ik aan mijn promotietraject begon, heb ik tijdens mijn afstudeerstage van 
moleculaire levenswetenschappen (MLW) een aantal geneeskunde studenten ontmoet die 
op dat moment hun WESP (wetenschapsparticipatie van geneeskunde) deden bij 
kindergeneeskunde. Voor mij waren zij een inspiratiebron om de geneeskundeopleiding te 
gaan doen. Nienke Wieringa, Thijs Flinsenberg, Heike Heineman, Patricia Sanders en 
Marijn Schuurman, ik heb met veel plezier geluisterd naar jullie boeiende verhalen over 
het vak geneeskunde, dank daarvoor. Tijdens de geneeskundeopleiding heb ik een 
ontzettend lieve vriendin leren kennen. Charelle Willems, op jou kan ik rekenen, je staat 
altijd voor me klaar. Bedankt voor je steun en gezelligheid. Ik vind het erg fijn dat je mijn 
paranimf wilt zijn. 
| Dankwoord 
 
 
| 108 
 
De weg die ik bewandeld heb is geen doorsnee route geweest en voor advies kon ik dan 
ook altijd terecht bij studieadviseur Guido Tans. Voor jou ook een woord van dank voor je 
adviezen om de combinatie studeren en promoveren tot een goed einde te brengen. 
Dan wil ik via deze weg graag nog iemand bedanken die ik vaak op de meest onverwachte 
momenten tegenkom en altijd een hoop plezier en gezelligheid met zich meebrengt. Eddy 
de Haan, waar ik je ook tegenkom, op het lab, in het ziekenhuis of ergens in de gangen 
van de universiteit, je bent altijd in voor een gezellig praatje. Dank voor de gezellige en 
grappige verhalen, dat ga ik zeker missen. 
 
Aan het einde van een lange werkdag is er niets zo fijn als thuis te komen  en samen te zijn 
met de mensen van wie je houdt en die er altijd voor je zijn. Lieve pappa en mamma,  
bedankt voor jullie onvoorwaardelijke steun en vertrouwen. Ik weet dat jullie me soms 
wel eens achter het behang konden plakken, maar jullie hebben me het 
doorzettingsvermogen gegeven om te komen waar ik nu ben. Bedankt voor de veilige 
thuishaven waar ik steeds op terug kon vallen; zonder jullie had ik dit nooit gekund! Ook 
mijn grote broer wil ik graag bedanken. Frank, bedankt voor je steun en betrokkenheid, 
jouw geduld en support hebben me steeds weer vooruit geholpen. Ik ben er trots op dat je 
vandaag mijn paranimf bent! 
 
Lieve Mike, als laatste wil ik jou bedanken dat je op mijn pad bent gekomen. Bij jou heb ik 
de ontspanning gevonden in deze hectische jaren van onderzoek en studeren. Bedankt 
voor je liefde en geduld, ik ben ‘happy’ met je! 
 
 
 
 
 
109 | 
 
 
 
 
Curriculum Vitae 
 
 
 
 
 
 
 
 
 
 
| Curriculum Vitae 
 
 
| 110 
 
Verena Anna Carolus Lambermont was born on October 16th 1984 
in Heerlen, the Netherlands. In 2003 she graduated from high 
school at Sophianum in Gulpen and subsequently started her study 
in Molecular Life Sciences at Maastricht University. After 
completion of her Bachelor’s degree in 2006, she stayed in 
Maastricht to pursue a Master’s degree in Clinical Molecular 
Sciences. During this period she did an internship, entitled 
“Antenatal exposure to inflammation affects immune response to 
postnatal sensitization to house dust mite in sheep”, under  supervision of prof. dr. Boris 
Kramer at the Department of Pediatrics of the Maastricht University Medical Center for 
which she obtained her Master’s degree in 2008. 
At this point her interest in the clinical care for patients was triggered and she started 
Medical School at Maastricht University. In 2011 she obtained her Bachelor’s degree and 
continued in Maastricht to pursue a Master’s degree in Medicine in 2014. Next to her 
medical school she did her PhD research. The end of her senior internship in 2008 was the 
beginning of her PhD project. During her PhD at the research group of prof. dr. Boris 
Kramer, she focused on aspects of lung development and bronchial hyperreactivity after 
antenatal exposure to inflammation, resulting in the current thesis.  
 
Verena Lambermont werd geboren op 16 oktober 1984 in Heerlen, Nederland. In 2003 
studeerde ze af van het Sophianum te Gulpen waarna ze aan haar studie Moleculaire 
Levenswetenschappen aan de Universiteit van Maastricht begon. Na het behalen van haar 
Bachelor diploma in 2006, startte ze een Master opleiding in Klinische Moleculaire 
Wetenschappen aan de Universiteit van Maastricht. Tijdens haar opleiding volgde ze een 
stage, getiteld “antenatale blootstelling aan een  inflammatie beïnvloedt de immuun- 
respons op postnatale sensitisatie voor huisstofmijt in schapen”, onder begeleiding van 
prof. dr. Boris Kramer bij de afdeling kindergeneeskunde van het Maastricht Universitair 
Medisch Centrum waarmee ze haar Master diploma behaalde in 2008. 
Op dat moment is haar interesse voor de klinische zorg van patiënten ontstaan en begint 
ze aan de opleiding Geneeskunde aan de universiteit van Maastricht. In 2011 behaalt ze 
haar Bachelor diploma en vervolgt ze de opleiding in Maastricht om uiteindelijk een 
Master diploma in de Geneeskunde te behalen in 2014. Haar Geneeskunde opleiding heeft 
ze gecombineerde met een PhD traject. Tijdens haar PhD bij de onderzoeksgroep van prof. 
dr. Boris Kramer, heeft ze zich vooral gericht op aspecten van longontwikkeling en 
bronchiale hyperreactiviteit na antenatale blootstelling aan een ontsteking, dat 
resulteerde in dit proefschrift. 
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